ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
R-HSA-9033241,Peroxisomal protein import,2/16,63/10899,0.003745471763940047,0.14960997165871276,0.10661972481725852,PIPOX/CROT,2
R-HSA-193704,p75 NTR receptor-mediated signalling,2/16,97/10899,0.008673691575254149,0.14960997165871276,0.10661972481725852,VAV3/IKBKB,2
R-HSA-425381,Bicarbonate transporters,1/16,10/10899,0.014589630297009437,0.14960997165871276,0.10661972481725852,SLC4A4,1
R-HSA-8963888,Chylomicron assembly,1/16,10/10899,0.014589630297009437,0.14960997165871276,0.10661972481725852,MTTP,1
R-HSA-2454202,Fc epsilon receptor (FCERI) signaling,2/16,134/10899,0.016084665710521334,0.14960997165871276,0.10661972481725852,VAV3/IKBKB,2
R-HSA-417957,P2Y receptors,1/16,12/10899,0.017483505841906166,0.14960997165871276,0.10661972481725852,P2RY1,1
R-HSA-71064,Lysine catabolism,1/16,12/10899,0.017483505841906166,0.14960997165871276,0.10661972481725852,PIPOX,1
R-HSA-73887,Death Receptor Signalling,2/16,146/10899,0.018911947542363593,0.14960997165871276,0.10661972481725852,VAV3/IKBKB,2
R-HSA-209543,p75NTR recruits signalling complexes,1/16,13/10899,0.018927454028416113,0.14960997165871276,0.10661972481725852,IKBKB,1
R-HSA-209560,NF-kB is activated and signals survival,1/16,13/10899,0.018927454028416113,0.14960997165871276,0.10661972481725852,IKBKB,1
R-HSA-933543,NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10,1/16,13/10899,0.018927454028416113,0.14960997165871276,0.10661972481725852,IKBKB,1
R-HSA-446652,Interleukin-1 family signaling,2/16,153/10899,0.0206519660182143,0.14960997165871276,0.10661972481725852,SMAD3/IKBKB,2
R-HSA-1502540,Signaling by Activin,1/16,15/10899,0.021809384039973345,0.14960997165871276,0.10661972481725852,SMAD3,1
R-HSA-937039,IRAK1 recruits IKK complex,1/16,15/10899,0.021809384039973345,0.14960997165871276,0.10661972481725852,IKBKB,1
R-HSA-9735871,SARS-CoV-1 targets host intracellular signalling and regulatory pathways,1/16,15/10899,0.021809384039973345,0.14960997165871276,0.10661972481725852,SMAD3,1
R-HSA-975144,IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation,1/16,15/10899,0.021809384039973345,0.14960997165871276,0.10661972481725852,IKBKB,1
R-HSA-193639,p75NTR signals via NF-kB,1/16,16/10899,0.023247370980010396,0.14960997165871276,0.10661972481725852,IKBKB,1
R-HSA-418038,Nucleotide-like (purinergic) receptors,1/16,16/10899,0.023247370980010396,0.14960997165871276,0.10661972481725852,P2RY1,1
R-HSA-5684264,MAP3K8 (TPL2)-dependent MAPK1/3 activation,1/16,16/10899,0.023247370980010396,0.14960997165871276,0.10661972481725852,IKBKB,1
R-HSA-70221,Glycogen breakdown (glycogenolysis),1/16,16/10899,0.023247370980010396,0.14960997165871276,0.10661972481725852,PHKA1,1
R-HSA-9609507,Protein localization,2/16,163/10899,0.023250475418173502,0.14960997165871276,0.10661972481725852,PIPOX/CROT,2
R-HSA-1810476,RIP-mediated NFkB activation via ZBP1,1/16,17/10899,0.024683375947787467,0.14960997165871276,0.10661972481725852,IKBKB,1
R-HSA-9617828,FOXO-mediated transcription of cell cycle genes,1/16,17/10899,0.024683375947787467,0.14960997165871276,0.10661972481725852,SMAD3,1
R-HSA-9754189,Germ layer formation at gastrulation,1/16,17/10899,0.024683375947787467,0.14960997165871276,0.10661972481725852,SMAD3,1
R-HSA-9758274,Regulation of NF-kappa B signaling,1/16,18/10899,0.026117401493168546,0.14960997165871276,0.10661972481725852,IKBKB,1
R-HSA-8963898,Plasma lipoprotein assembly,1/16,19/10899,0.027549450162969835,0.14960997165871276,0.10661972481725852,MTTP,1
R-HSA-9758941,Gastrulation,1/16,19/10899,0.027549450162969835,0.14960997165871276,0.10661972481725852,SMAD3,1
R-HSA-168927,"TICAM1, RIP1-mediated IKK complex recruitment",1/16,20/10899,0.02897952450096586,0.14960997165871276,0.10661972481725852,IKBKB,1
R-HSA-9013695,NOTCH4 Intracellular Domain Regulates Transcription,1/16,20/10899,0.02897952450096586,0.14960997165871276,0.10661972481725852,SMAD3,1
R-HSA-1606322,ZBP1(DAI) mediated induction of type I IFNs,1/16,21/10899,0.03040762704788924,0.14960997165871276,0.10661972481725852,IKBKB,1
R-HSA-9008059,Interleukin-37 signaling,1/16,21/10899,0.03040762704788924,0.14960997165871276,0.10661972481725852,SMAD3,1
R-HSA-1181150,Signaling by NODAL,1/16,22/10899,0.03183376034143881,0.14960997165871276,0.10661972481725852,SMAD3,1
R-HSA-71403,Citric acid cycle (TCA cycle),1/16,22/10899,0.03183376034143881,0.14960997165871276,0.10661972481725852,SUCLG2,1
R-HSA-9748787,Azathioprine ADME,1/16,24/10899,0.03468012930404496,0.14960997165871276,0.10661972481725852,VAV3,1
R-HSA-418592,ADP signalling through P2Y purinoceptor 1,1/16,25/10899,0.03610037003334454,0.14960997165871276,0.10661972481725852,P2RY1,1
R-HSA-933542,TRAF6 mediated NF-kB activation,1/16,25/10899,0.03610037003334454,0.14960997165871276,0.10661972481725852,IKBKB,1
R-HSA-937041,IKK complex recruitment mediated by RIP1,1/16,25/10899,0.03610037003334454,0.14960997165871276,0.10661972481725852,IKBKB,1
R-HSA-2173788,Downregulation of TGF-beta receptor signaling,1/16,26/10899,0.03751865162976409,0.14960997165871276,0.10661972481725852,SMAD3,1
R-HSA-8982491,Glycogen metabolism,1/16,27/10899,0.03893497661586931,0.14960997165871276,0.10661972481725852,PHKA1,1
R-HSA-390918,Peroxisomal lipid metabolism,1/16,29/10899,0.041761766832323466,0.14960997165871276,0.10661972481725852,CROT,1
R-HSA-5218920,VEGFR2 mediated vascular permeability,1/16,29/10899,0.041761766832323466,0.14960997165871276,0.10661972481725852,VAV3,1
R-HSA-9615017,"FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes",1/16,29/10899,0.041761766832323466,0.14960997165871276,0.10661972481725852,SMAD3,1
R-HSA-2173795,Downregulation of SMAD2/3:SMAD4 transcriptional activity,1/16,30/10899,0.04317223709273599,0.14960997165871276,0.10661972481725852,SMAD3,1
R-HSA-2424491,DAP12 signaling,1/16,30/10899,0.04317223709273599,0.14960997165871276,0.10661972481725852,VAV3,1
R-HSA-5357956,TNFR1-induced NFkappaB signaling pathway,1/16,30/10899,0.04317223709273599,0.14960997165871276,0.10661972481725852,IKBKB,1
R-HSA-5260271,Diseases of Immune System,1/16,31/10899,0.04458076080296869,0.14960997165871276,0.10661972481725852,IKBKB,1
R-HSA-5602358,Diseases associated with the TLR signaling cascade,1/16,31/10899,0.04458076080296869,0.14960997165871276,0.10661972481725852,IKBKB,1
R-HSA-2871796,FCERI mediated MAPK activation,1/16,32/10899,0.04598734047053843,0.14960997165871276,0.10661972481725852,VAV3,1
R-HSA-2871809,FCERI mediated Ca+2 mobilization,1/16,33/10899,0.04739197859996491,0.14960997165871276,0.10661972481725852,VAV3,1
R-HSA-392518,Signal amplification,1/16,33/10899,0.04739197859996491,0.14960997165871276,0.10661972481725852,P2RY1,1
R-HSA-8963899,Plasma lipoprotein remodeling,1/16,33/10899,0.04739197859996491,0.14960997165871276,0.10661972481725852,MTTP,1
R-HSA-192105,Synthesis of bile acids and bile salts,1/16,34/10899,0.04879467769276802,0.15107582901030098,0.10766436980792943,OSBPL3,1
R-HSA-114604,GPVI-mediated activation cascade,1/16,35/10899,0.05019544024747702,0.15248048829893962,0.10866540192601777,VAV3,1
R-HSA-2173796,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,1/16,36/10899,0.05159426875963091,0.15382735685741808,0.10962524941130156,SMAD3,1
R-HSA-168638,NOD1/2 Signaling Pathway,1/16,37/10899,0.052991165721782085,0.1551195942037621,0.1105461638980717,IKBKB,1
R-HSA-76002,"Platelet activation, signaling and aggregation",2/16,263/10899,0.05573276120024598,0.15600706851578042,0.11117862352546629,VAV3/P2RY1,2
R-HSA-390471,Association of TriC/CCT with target proteins during biosynthesis,1/16,39/10899,0.05577917495137208,0.15600706851578042,0.11117862352546629,ARFGEF2,1
R-HSA-5357905,Regulation of TNFR1 signaling,1/16,40/10899,0.057170292189012706,0.15600706851578042,0.11117862352546629,IKBKB,1
R-HSA-9013420,RHOU GTPase cycle,1/16,40/10899,0.057170292189012706,0.15600706851578042,0.11117862352546629,ITSN2,1
R-HSA-6811438,Intra-Golgi traffic,1/16,44/10899,0.06271556980551429,0.16380370956349166,0.11673490907107285,COG5,1
R-HSA-194068,Bile acid and bile salt metabolism,1/16,45/10899,0.06409710374223587,0.16380370956349166,0.11673490907107285,OSBPL3,1
R-HSA-2172127,DAP12 interactions,1/16,45/10899,0.06409710374223587,0.16380370956349166,0.11673490907107285,VAV3,1
R-HSA-445989,TAK1-dependent IKK and NF-kappa-B activation  ,1/16,45/10899,0.06409710374223587,0.16380370956349166,0.11673490907107285,IKBKB,1
R-HSA-2173789,TGF-beta receptor signaling activates SMADs,1/16,46/10899,0.06547672842807695,0.16471489495188107,0.11738426642533532,SMAD3,1
R-HSA-6811440,Retrograde transport at the Trans-Golgi-Network,1/16,49/10899,0.06960417159425925,0.1697919943435718,0.12100246736482069,COG5,1
R-HSA-75893,TNF signaling,1/16,49/10899,0.06960417159425925,0.1697919943435718,0.12100246736482069,IKBKB,1
R-HSA-2173793,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,1/16,51/10899,0.07234629919129132,0.17129050249702799,0.12207038098840177,SMAD3,1
R-HSA-3928665,EPH-ephrin mediated repulsion of cells,1/16,51/10899,0.07234629919129132,0.17129050249702799,0.12207038098840177,VAV3,1
R-HSA-71406,Pyruvate metabolism and Citric Acid (TCA) cycle,1/16,55/10899,0.0778078397122518,0.18110155514012727,0.12906223936105832,SUCLG2,1
R-HSA-168643,"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways",1/16,57/10899,0.08052729168934925,0.18110155514012727,0.12906223936105832,IKBKB,1
R-HSA-193648,NRAGE signals death through JNK,1/16,59/10899,0.08323922410167339,0.18110155514012727,0.12906223936105832,VAV3,1
R-HSA-9664407,Parasite infection,1/16,59/10899,0.08323922410167339,0.18110155514012727,0.12906223936105832,VAV3,1
R-HSA-9664417,Leishmania phagocytosis,1/16,59/10899,0.08323922410167339,0.18110155514012727,0.12906223936105832,VAV3,1
R-HSA-9664422,FCGR3A-mediated phagocytosis,1/16,59/10899,0.08323922410167339,0.18110155514012727,0.12906223936105832,VAV3,1
R-HSA-2029482,Regulation of actin dynamics for phagocytic cup formation,1/16,61/10899,0.08594365635901424,0.18449238231735055,0.13147871639484285,VAV3,1
R-HSA-1834949,Cytosolic sensors of pathogen-associated DNA ,1/16,64/10899,0.08998628429886779,0.18815313989763266,0.13408755965244826,IKBKB,1
R-HSA-450294,MAP kinase activation,1/16,64/10899,0.08998628429886779,0.18815313989763266,0.13408755965244826,IKBKB,1
R-HSA-9614085,FOXO-mediated transcription,1/16,65/10899,0.09133009781536316,0.18851468908042912,0.13434521810896877,SMAD3,1
R-HSA-1169091,Activation of NF-kappaB in B cells,1/16,67/10899,0.09401214560170879,0.1915943726819635,0.1365399583022819,IKBKB,1
R-HSA-448424,Interleukin-17 signaling,1/16,72/10899,0.10068483146928442,0.19954759910979802,0.1422078346058711,IKBKB,1
R-HSA-909733,Interferon alpha/beta signaling,1/16,72/10899,0.10068483146928442,0.19954759910979802,0.1422078346058711,XAF1,1
R-HSA-174824,"Plasma lipoprotein assembly, remodeling, and clearance",1/16,74/10899,0.1033409826291094,0.19954759910979802,0.1422078346058711,MTTP,1
R-HSA-9013408,RHOG GTPase cycle,1/16,74/10899,0.1033409826291094,0.19954759910979802,0.1422078346058711,VAV3,1
R-HSA-204998,"Cell death signalling via NRAGE, NRIF and NADE",1/16,76/10899,0.10598977773129914,0.19954759910979802,0.1422078346058711,VAV3,1
R-HSA-416482,G alpha (12/13) signalling events,1/16,80/10899,0.11126537578728868,0.19954759910979802,0.1422078346058711,VAV3,1
R-HSA-168928,DDX58/IFIH1-mediated induction of interferon-alpha/beta,1/16,82/10899,0.11389221663929183,0.19954759910979802,0.1422078346058711,IKBKB,1
R-HSA-2871837,FCERI mediated NF-kB activation,1/16,82/10899,0.11389221663929183,0.19954759910979802,0.1422078346058711,IKBKB,1
R-HSA-9013694,Signaling by NOTCH4,1/16,82/10899,0.11389221663929183,0.19954759910979802,0.1422078346058711,SMAD3,1
R-HSA-1168372,Downstream signaling events of B Cell Receptor (BCR),1/16,83/10899,0.1152029057891274,0.19954759910979802,0.1422078346058711,IKBKB,1
R-HSA-2029480,Fcgamma receptor (FCGR) dependent phagocytosis,1/16,86/10899,0.11912407639571765,0.19954759910979802,0.1422078346058711,VAV3,1
R-HSA-9679506,SARS-CoV Infections,2/16,413/10899,0.12126691231218262,0.19954759910979802,0.1422078346058711,SMAD3/IKBKB,2
R-HSA-9013404,RAC2 GTPase cycle,1/16,88/10899,0.12172913292588472,0.19954759910979802,0.1422078346058711,VAV3,1
R-HSA-1236974,ER-Phagosome pathway,1/16,90/10899,0.12432696556585288,0.19954759910979802,0.1422078346058711,IKBKB,1
R-HSA-390466,Chaperonin-mediated protein folding,1/16,91/10899,0.12562317877252716,0.19954759910979802,0.1422078346058711,ARFGEF2,1
R-HSA-2682334,EPH-Ephrin signaling,1/16,92/10899,0.12691759301564687,0.19954759910979802,0.1422078346058711,VAV3,1
R-HSA-170834,Signaling by TGF-beta Receptor Complex,1/16,93/10899,0.12821021062569127,0.19954759910979802,0.1422078346058711,SMAD3,1
R-HSA-9692914,SARS-CoV-1-host interactions,1/16,95/10899,0.1307900652544557,0.19954759910979802,0.1422078346058711,SMAD3,1
R-HSA-8878159,Transcriptional regulation by RUNX3,1/16,96/10899,0.13207730692012865,0.19954759910979802,0.1422078346058711,SMAD3,1
R-HSA-168142,Toll Like Receptor 10 (TLR10) Cascade,1/16,97/10899,0.1333627612466377,0.19954759910979802,0.1422078346058711,IKBKB,1
R-HSA-168176,Toll Like Receptor 5 (TLR5) Cascade,1/16,97/10899,0.1333627612466377,0.19954759910979802,0.1422078346058711,IKBKB,1
R-HSA-391251,Protein folding,1/16,97/10899,0.1333627612466377,0.19954759910979802,0.1422078346058711,ARFGEF2,1
R-HSA-975871,MyD88 cascade initiated on plasma membrane,1/16,97/10899,0.1333627612466377,0.19954759910979802,0.1422078346058711,IKBKB,1
R-HSA-202424,Downstream TCR signaling,1/16,98/10899,0.1346464305504752,0.19954759910979802,0.1422078346058711,IKBKB,1
R-HSA-5619102,SLC transporter disorders,1/16,98/10899,0.1346464305504752,0.19954759910979802,0.1422078346058711,SLC4A4,1
R-HSA-4420097,VEGFA-VEGFR2 Pathway,1/16,99/10899,0.13592831714534526,0.19954759910979802,0.1422078346058711,VAV3,1
R-HSA-5607764,CLEC7A (Dectin-1) signaling,1/16,101/10899,0.13848675144907752,0.19954759910979802,0.1422078346058711,IKBKB,1
R-HSA-6807878,COPI-mediated anterograde transport,1/16,101/10899,0.13848675144907752,0.19954759910979802,0.1422078346058711,COG5,1
R-HSA-9012999,RHO GTPase cycle,2/16,449/10899,0.1390907829516119,0.19954759910979802,0.1422078346058711,VAV3/ITSN2,2
R-HSA-975138,TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,1/16,103/10899,0.14103808261182194,0.19954759910979802,0.1422078346058711,IKBKB,1
R-HSA-975155,MyD88 dependent cascade initiated on endosome,1/16,104/10899,0.14231109027004807,0.19954759910979802,0.1422078346058711,IKBKB,1
R-HSA-1236975,Antigen processing-Cross presentation,1/16,105/10899,0.14358232904315404,0.19954759910979802,0.1422078346058711,IKBKB,1
R-HSA-168164,Toll Like Receptor 3 (TLR3) Cascade,1/16,105/10899,0.14358232904315404,0.19954759910979802,0.1422078346058711,IKBKB,1
R-HSA-168181,Toll Like Receptor 7/8 (TLR7/8) Cascade,1/16,105/10899,0.14358232904315404,0.19954759910979802,0.1422078346058711,IKBKB,1
R-HSA-8856825,Cargo recognition for clathrin-mediated endocytosis,1/16,106/10899,0.14485180122541352,0.19954759910979802,0.1422078346058711,ITSN2,1
R-HSA-168138,Toll Like Receptor 9 (TLR9) Cascade,1/16,108/10899,0.14738545498067468,0.19954759910979802,0.1422078346058711,IKBKB,1
R-HSA-194138,Signaling by VEGF,1/16,108/10899,0.14738545498067468,0.19954759910979802,0.1422078346058711,VAV3,1
R-HSA-425393,Transport of inorganic cations/anions and amino acids/oligopeptides,1/16,108/10899,0.14738545498067468,0.19954759910979802,0.1422078346058711,SLC4A4,1
R-HSA-9748784,Drug ADME,1/16,108/10899,0.14738545498067468,0.19954759910979802,0.1422078346058711,VAV3,1
R-HSA-166166,MyD88-independent TLR4 cascade ,1/16,110/10899,0.1499120698348091,0.19954759910979802,0.1422078346058711,IKBKB,1
R-HSA-937061,TRIF(TICAM1)-mediated TLR4 signaling ,1/16,110/10899,0.1499120698348091,0.19954759910979802,0.1422078346058711,IKBKB,1
R-HSA-449147,Signaling by Interleukins,2/16,473/10899,0.15130228645493107,0.19954759910979802,0.1422078346058711,SMAD3/IKBKB,2
R-HSA-983705,Signaling by the B Cell Receptor (BCR),1/16,112/10899,0.15243166404272612,0.19954759910979802,0.1422078346058711,IKBKB,1
R-HSA-166058,MyD88:MAL(TIRAP) cascade initiated on plasma membrane,1/16,113/10899,0.1536888340969873,0.19954759910979802,0.1422078346058711,IKBKB,1
R-HSA-168188,Toll Like Receptor TLR6:TLR2 Cascade,1/16,113/10899,0.1536888340969873,0.19954759910979802,0.1422078346058711,IKBKB,1
R-HSA-9020702,Interleukin-1 signaling,1/16,115/10899,0.15619793146737992,0.19960179523219054,0.14224645753716095,IKBKB,1
R-HSA-168179,Toll Like Receptor TLR1:TLR2 Cascade,1/16,116/10899,0.15744986331980249,0.19960179523219054,0.14224645753716095,IKBKB,1
R-HSA-181438,Toll Like Receptor 2 (TLR2) Cascade,1/16,116/10899,0.15744986331980249,0.19960179523219054,0.14224645753716095,IKBKB,1
R-HSA-202403,TCR signaling,1/16,120/10899,0.16244019797355536,0.2043193115136126,0.14560840114405868,IKBKB,1
R-HSA-9006936,Signaling by TGFB family members,1/16,122/10899,0.16492496123853195,0.2058365795302608,0.14668968400652782,SMAD3,1
R-HSA-9705671,SARS-CoV-2 activates/modulates innate and adaptive immune responses,1/16,126/10899,0.16987376960756417,0.21038213005244485,0.14992907600991492,IKBKB,1
R-HSA-9678108,SARS-CoV-1 Infection,1/16,141/10899,0.1881879994309662,0.231004970136303,0.1646259676028573,SMAD3,1
R-HSA-5621481,C-type lectin receptors (CLRs),1/16,142/10899,0.1893953792421863,0.231004970136303,0.1646259676028573,IKBKB,1
R-HSA-166016,Toll Like Receptor 4 (TLR4) Cascade,1/16,146/10899,0.1942080841907522,0.23304102158772816,0.16607696209913284,IKBKB,1
R-HSA-8856828,Clathrin-mediated endocytosis,1/16,146/10899,0.1942080841907522,0.23304102158772816,0.16607696209913284,ITSN2,1
R-HSA-8980692,RHOA GTPase cycle,1/16,147/10899,0.19540706779095218,0.23304102158772816,0.16607696209913284,VAV3,1
R-HSA-199977,ER to Golgi Anterograde Transport,1/16,154/10899,0.20375323948950996,0.23909538615450077,0.17039161223171354,COG5,1
R-HSA-8957322,Metabolism of steroids,1/16,154/10899,0.20375323948950996,0.23909538615450077,0.17039161223171354,OSBPL3,1
R-HSA-9013148,CDC42 GTPase cycle,1/16,155/10899,0.2049389024181435,0.23909538615450077,0.17039161223171354,VAV3,1
R-HSA-9658195,Leishmania infection,1/16,164/10899,0.21553563691307165,0.24964919095686713,0.177912793816924,VAV3,1
R-HSA-168898,Toll-like Receptor Cascades,1/16,168/10899,0.220202667407019,0.25323306751807184,0.1804668477245494,IKBKB,1
R-HSA-5619115,Disorders of transmembrane transporters,1/16,176/10899,0.22945874406026123,0.2609287765803964,0.1859512039703381,SLC4A4,1
R-HSA-8978868,Fatty acid metabolism,1/16,177/10899,0.23060848388074384,0.2609287765803964,0.1859512039703381,CROT,1
R-HSA-1428517,The citric acid (TCA) cycle and respiratory electron transport,1/16,178/10899,0.23175661522358193,0.2609287765803964,0.1859512039703381,SUCLG2,1
R-HSA-9013149,RAC1 GTPase cycle,1/16,185/10899,0.23974867336475025,0.2662036993912055,0.1897103840055011,VAV3,1
R-HSA-948021,Transport to the Golgi and subsequent modification,1/16,185/10899,0.23974867336475025,0.2662036993912055,0.1897103840055011,COG5,1
R-HSA-913531,Interferon Signaling,1/16,200/10899,0.2566127842425471,0.2815701231606962,0.20066128424005156,XAF1,1
R-HSA-6811442,Intra-Golgi and retrograde Golgi-to-ER traffic,1/16,202/10899,0.25883464737753437,0.2815701231606962,0.20066128424005156,COG5,1
R-HSA-9705683,SARS-CoV-2-host interactions,1/16,202/10899,0.25883464737753437,0.2815701231606962,0.20066128424005156,IKBKB,1
R-HSA-416476,G alpha (q) signalling events,1/16,216/10899,0.27421424562400654,0.29629861439909433,0.2111575610951375,P2RY1,1
R-HSA-5689880,Ub-specific processing proteases,1/16,220/10899,0.27855315167271244,0.298980382795378,0.2130687265426362,SMAD3,1
R-HSA-157118,Signaling by NOTCH,1/16,236/10899,0.295666777842863,0.31524735915695984,0.22466140665648007,SMAD3,1
R-HSA-425407,SLC-mediated transmembrane transport,1/16,250/10899,0.3103282653613385,0.3287029652840493,0.2342505604181849,SLC4A4,1
R-HSA-71387,Metabolism of carbohydrates,1/16,295/10899,0.3555400826376801,0.3723287721389726,0.26534054372767574,PHKA1,1
R-HSA-5688426,Deubiquitination,1/16,298/10899,0.35845316572385555,0.3723287721389726,0.26534054372767574,SMAD3,1
R-HSA-9694516,SARS-CoV-2 Infection,1/16,298/10899,0.35845316572385555,0.3723287721389726,0.26534054372767574,IKBKB,1
R-HSA-446203,Asparagine N-linked glycosylation,1/16,304/10899,0.36424233614533763,0.37591676999614976,0.2678975346817935,COG5,1
R-HSA-373076,Class A/1 (Rhodopsin-like receptors),1/16,335/10899,0.39338092918820633,0.4034033732439568,0.28748589528336904,P2RY1,1
R-HSA-71291,Metabolism of amino acids and derivatives,1/16,374/10899,0.42826187514329495,0.43639342973462336,0.3109962984051909,PIPOX,1
R-HSA-983169,Class I MHC mediated antigen processing & presentation,1/16,381/10899,0.43431997185736837,0.4397831161574611,0.3134119624790013,IKBKB,1
R-HSA-5663202,Diseases of signal transduction by growth factor receptors and second messengers,1/16,433/10899,0.47747481671621106,0.48045903432068743,0.34239970409254605,SMAD3,1
R-HSA-500792,GPCR ligand binding,1/16,467/10899,0.5040012879395717,0.5040012879395717,0.3591771192246702,P2RY1,1
HALLMARK_BILE_ACID_METABOLISM,HALLMARK_BILE_ACID_METABOLISM,2/12,112/4383,0.03614003944522708,0.42946343002256193,0.4254746055951078,PIPOX/CROT,2
HALLMARK_TGF_BETA_SIGNALING,HALLMARK_TGF_BETA_SIGNALING,1/12,54/4383,0.13838815271355542,0.42946343002256193,0.4254746055951078,SMAD3,1
HALLMARK_PROTEIN_SECRETION,HALLMARK_PROTEIN_SECRETION,1/12,96/4383,0.23363184571083262,0.42946343002256193,0.4254746055951078,ARFGEF2,1
HALLMARK_INTERFERON_ALPHA_RESPONSE,HALLMARK_INTERFERON_ALPHA_RESPONSE,1/12,97/4383,0.2357770329866593,0.42946343002256193,0.4254746055951078,SAMD9,1
HALLMARK_PI3K_AKT_MTOR_SIGNALING,HALLMARK_PI3K_AKT_MTOR_SIGNALING,1/12,105/4383,0.252741404987866,0.42946343002256193,0.4254746055951078,VAV3,1
HALLMARK_COAGULATION,HALLMARK_COAGULATION,1/12,138/4383,0.31913390073366643,0.42946343002256193,0.4254746055951078,P2RY1,1
HALLMARK_UV_RESPONSE_DN,HALLMARK_UV_RESPONSE_DN,1/12,144/4383,0.33060756476407016,0.42946343002256193,0.4254746055951078,SMAD3,1
HALLMARK_FATTY_ACID_METABOLISM,HALLMARK_FATTY_ACID_METABOLISM,1/12,158/4383,0.35669353791938496,0.42946343002256193,0.4254746055951078,SUCLG2,1
HALLMARK_ALLOGRAFT_REJECTION,HALLMARK_ALLOGRAFT_REJECTION,1/12,200/4383,0.42946343002256193,0.42946343002256193,0.4254746055951078,IKBKB,1
HALLMARK_ESTROGEN_RESPONSE_EARLY,HALLMARK_ESTROGEN_RESPONSE_EARLY,1/12,200/4383,0.42946343002256193,0.42946343002256193,0.4254746055951078,AFF1,1
HALLMARK_ESTROGEN_RESPONSE_LATE,HALLMARK_ESTROGEN_RESPONSE_LATE,1/12,200/4383,0.42946343002256193,0.42946343002256193,0.4254746055951078,AFF1,1
HALLMARK_G2M_CHECKPOINT,HALLMARK_G2M_CHECKPOINT,1/12,200/4383,0.42946343002256193,0.42946343002256193,0.4254746055951078,SMAD3,1
HALLMARK_INFLAMMATORY_RESPONSE,HALLMARK_INFLAMMATORY_RESPONSE,1/12,200/4383,0.42946343002256193,0.42946343002256193,0.4254746055951078,SLC4A4,1
HALLMARK_INTERFERON_GAMMA_RESPONSE,HALLMARK_INTERFERON_GAMMA_RESPONSE,1/12,200/4383,0.42946343002256193,0.42946343002256193,0.4254746055951078,XAF1,1
HALLMARK_KRAS_SIGNALING_UP,HALLMARK_KRAS_SIGNALING_UP,1/12,200/4383,0.42946343002256193,0.42946343002256193,0.4254746055951078,CROT,1
HALLMARK_TNFA_SIGNALING_VIA_NFKB,HALLMARK_TNFA_SIGNALING_VIA_NFKB,1/12,200/4383,0.42946343002256193,0.42946343002256193,0.4254746055951078,SMAD3,1
HALLMARK_XENOBIOTIC_METABOLISM,HALLMARK_XENOBIOTIC_METABOLISM,1/12,200/4383,0.42946343002256193,0.42946343002256193,0.4254746055951078,CROT,1
VERHAAK_GLIOBLASTOMA_CLASSICAL,VERHAAK_GLIOBLASTOMA_CLASSICAL,4/23,161/21728,2.3039467568782328e-5,0.016703613987367187,0.01081642372176518,SLC4A4/OSBPL3/VAV3/PIPOX,4
NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER,NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER,3/23,94/21728,1.3041670189593087e-4,0.04263707985309039,0.027609637189805178,SAMD9/ARFGEF2/IKBKB,3
WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,2/23,22/21728,2.4442551623346813e-4,0.04263707985309039,0.027609637189805178,SMAD3/IKBKB,2
BIOCARTA_NTHI_PATHWAY,BIOCARTA_NTHI_PATHWAY,2/23,23/21728,2.6753179087818336e-4,0.04263707985309039,0.027609637189805178,SMAD3/IKBKB,2
FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS,FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS,4/23,311/21728,2.9404882657303716e-4,0.04263707985309039,0.027609637189805178,SMAD3/ARFGEF2/CROT/COBLL1,4
PID_CDC42_REG_PATHWAY,PID_CDC42_REG_PATHWAY,2/23,30/21728,4.579169276341367e-4,0.0514577761393509,0.03332147826954702,VAV3/ITSN2,2
WANG_LMO4_TARGETS_DN,WANG_LMO4_TARGETS_DN,4/23,361/21728,5.168165686910474e-4,0.0514577761393509,0.03332147826954702,COG5/SAMD9/ARFGEF2/COBLL1,4
DESERT_PERIVENOUS_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,DESERT_PERIVENOUS_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,3/23,155/21728,5.678099436066306e-4,0.0514577761393509,0.03332147826954702,SMAD3/SLC4A4/MTTP,3
DOANE_RESPONSE_TO_ANDROGEN_UP,DOANE_RESPONSE_TO_ANDROGEN_UP,3/23,184/21728,9.339324249998934e-4,0.07393532858465698,0.04787681531579967,AFF1/CROT/TTC12,3
JOHNSTONE_PARVB_TARGETS_3_UP,JOHNSTONE_PARVB_TARGETS_3_UP,4/23,433/21728,0.0010197976356504412,0.07393532858465698,0.04787681531579967,SMAD3/MDFIC/OSBPL3/IKBKB,4
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN,CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN,4/23,456/21728,0.0012351288982301357,0.08000109539254399,0.05180470206181434,SMAD3/MDFIC/SAMD9/OSBPL3,4
STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN,STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN,2/23,51/21728,0.0013241560616696936,0.08000109539254399,0.05180470206181434,SAMD9/XAF1,2
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP,BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP,2/23,59/21728,0.0017678480094691787,0.09859152360501189,0.06384293216382622,MDFIC/VAV3,2
REACTOME_PEROXISOMAL_PROTEIN_IMPORT,REACTOME_PEROXISOMAL_PROTEIN_IMPORT,2/23,63/21728,0.002012706449465321,0.10208734645510771,0.06610665193318047,PIPOX/CROT,2
WP_AGERAGE_PATHWAY,WP_AGERAGE_PATHWAY,2/23,66/21728,0.0022063179138761438,0.10208734645510771,0.06610665193318047,SMAD3/IKBKB,2
KEGG_PANCREATIC_CANCER,KEGG_PANCREATIC_CANCER,2/23,70/21728,0.0024776592726105913,0.10208734645510771,0.06610665193318047,SMAD3/IKBKB,2
BOYLAN_MULTIPLE_MYELOMA_PCA3_DN,BOYLAN_MULTIPLE_MYELOMA_PCA3_DN,2/23,71/21728,0.0025478378572349296,0.10208734645510771,0.06610665193318047,PHKA1/SUCLG2,2
KEGG_CHRONIC_MYELOID_LEUKEMIA,KEGG_CHRONIC_MYELOID_LEUKEMIA,2/23,73/21728,0.0026909937352534463,0.10208734645510771,0.06610665193318047,SMAD3/IKBKB,2
KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY,KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY,2/23,75/21728,0.002837868707255821,0.10208734645510771,0.06610665193318047,VAV3/IKBKB,2
KEGG_PEROXISOME,KEGG_PEROXISOME,2/23,78/21728,0.0030651216995966424,0.10208734645510771,0.06610665193318047,PIPOX/CROT,2
WOO_LIVER_CANCER_RECURRENCE_DN,WOO_LIVER_CANCER_RECURRENCE_DN,2/23,78/21728,0.0030651216995966424,0.10208734645510771,0.06610665193318047,MTTP/PIPOX,2
BOYLAN_MULTIPLE_MYELOMA_C_D_DN,BOYLAN_MULTIPLE_MYELOMA_C_D_DN,3/23,280/21728,0.003097822926913613,0.10208734645510771,0.06610665193318047,MDFIC/OSBPL3/VAV3,3
SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN,SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN,2/23,81/21728,0.0033006585531879444,0.10229568109956913,0.06624155901329633,VAV3/IKBKB,2
GABRIELY_MIR21_TARGETS,GABRIELY_MIR21_TARGETS,3/23,289/21728,0.003386339788123668,0.10229568109956913,0.06624155901329633,OSBPL3/COBLL1/ITSN2,3
WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,2/23,89/21728,0.003968874735936826,0.10840155259363689,0.07019541554520807,SMAD3/IKBKB,2
JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_DN,JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_DN,3/23,308/21728,0.004048445832846578,0.10840155259363689,0.07019541554520807,SAMD9/SLC4A4/XAF1,3
WP_TCELL_RECEPTOR_TCR_SIGNALING_PATHWAY,WP_TCELL_RECEPTOR_TCR_SIGNALING_PATHWAY,2/23,91/21728,0.004144966539095093,0.10840155259363689,0.07019541554520807,VAV3/IKBKB,2
KIM_MYCN_AMPLIFICATION_TARGETS_UP,KIM_MYCN_AMPLIFICATION_TARGETS_UP,2/23,93/21728,0.0043246440812684086,0.10840155259363689,0.07019541554520807,PHKA1/P2RY1,2
HECKER_IFNB1_TARGETS,HECKER_IFNB1_TARGETS,2/23,95/21728,0.00450789275274249,0.10840155259363689,0.07019541554520807,SAMD9/XAF1,2
HOEBEKE_LYMPHOID_STEM_CELL_UP,HOEBEKE_LYMPHOID_STEM_CELL_UP,2/23,97/21728,0.004694697984945818,0.10840155259363689,0.07019541554520807,OSBPL3/ITSN2,2
REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING,REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING,2/23,97/21728,0.004694697984945818,0.10840155259363689,0.07019541554520807,VAV3/IKBKB,2
FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL,FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL,3/23,327/21728,0.0047846202524088,0.10840155259363689,0.07019541554520807,SMAD3/CROT/IKBKB,3
KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY,KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY,2/23,108/21728,0.005785053141521903,0.11484150535351798,0.07436560637048135,VAV3/IKBKB,2
SANSOM_APC_TARGETS_DN,SANSOM_APC_TARGETS_DN,3/23,361/21728,0.006294251215237375,0.11484150535351798,0.07436560637048135,SLC4A4/MTTP/PIPOX,3
BOYLAN_MULTIPLE_MYELOMA_PCA1_UP,BOYLAN_MULTIPLE_MYELOMA_PCA1_UP,2/23,126/21728,0.007794148360301779,0.11484150535351798,0.07436560637048135,OSBPL3/VAV3,2
KEGG_INSULIN_SIGNALING_PATHWAY,KEGG_INSULIN_SIGNALING_PATHWAY,2/23,137/21728,0.009155605001880679,0.11484150535351798,0.07436560637048135,PHKA1/IKBKB,2
REACTOME_INTERLEUKIN_1_FAMILY_SIGNALING,REACTOME_INTERLEUKIN_1_FAMILY_SIGNALING,2/23,140/21728,0.009544122468392214,0.11484150535351798,0.07436560637048135,SMAD3/IKBKB,2
REACTOME_DEATH_RECEPTOR_SIGNALLING,REACTOME_DEATH_RECEPTOR_SIGNALLING,2/23,141/21728,0.009675250285419323,0.11484150535351798,0.07436560637048135,VAV3/IKBKB,2
SHEN_SMARCA2_TARGETS_UP,SHEN_SMARCA2_TARGETS_UP,3/23,428/21728,0.010030363069712873,0.11484150535351798,0.07436560637048135,SUCLG2/ARFGEF2/ITSN2,3
WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING_PATHWAY,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING_PATHWAY,2/23,144/21728,0.010073475852904211,0.11484150535351798,0.07436560637048135,VAV3/IKBKB,2
WP_ENDODERM_DIFFERENTIATION,WP_ENDODERM_DIFFERENTIATION,2/23,145/21728,0.010207826080824347,0.11484150535351798,0.07436560637048135,SMAD3/VAV3,2
BOYAULT_LIVER_CANCER_SUBCLASS_G23_DN,BOYAULT_LIVER_CANCER_SUBCLASS_G23_DN,1/23,10/21728,0.010537310942466127,0.11484150535351798,0.07436560637048135,COBLL1,1
KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN,KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN,1/23,10/21728,0.010537310942466127,0.11484150535351798,0.07436560637048135,SUCLG2,1
MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_DN,MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_DN,1/23,10/21728,0.010537310942466127,0.11484150535351798,0.07436560637048135,MDFIC,1
REACTOME_BICARBONATE_TRANSPORTERS,REACTOME_BICARBONATE_TRANSPORTERS,1/23,10/21728,0.010537310942466127,0.11484150535351798,0.07436560637048135,SLC4A4,1
REACTOME_CHYLOMICRON_ASSEMBLY,REACTOME_CHYLOMICRON_ASSEMBLY,1/23,10/21728,0.010537310942466127,0.11484150535351798,0.07436560637048135,MTTP,1
VANTVEER_BREAST_CANCER_ESR1_UP,VANTVEER_BREAST_CANCER_ESR1_UP,2/23,149/21728,0.010753223664560347,0.11484150535351798,0.07436560637048135,AFF1/VAV3,2
WP_HEPATITIS_B_INFECTION,WP_HEPATITIS_B_INFECTION,2/23,154/21728,0.011452836652172465,0.11484150535351798,0.07436560637048135,SMAD3/IKBKB,2
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_DN,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_DN,1/23,11/21728,0.011585180997181865,0.11484150535351798,0.07436560637048135,SMAD3,1
WP_NUCLEOTIDE_GPCRS,WP_NUCLEOTIDE_GPCRS,1/23,11/21728,0.011585180997181865,0.11484150535351798,0.07436560637048135,P2RY1,1
YEMELYANOV_GR_TARGETS_DN,YEMELYANOV_GR_TARGETS_DN,1/23,11/21728,0.011585180997181865,0.11484150535351798,0.07436560637048135,SMAD3,1
WP_MESODERMAL_COMMITMENT_PATHWAY,WP_MESODERMAL_COMMITMENT_PATHWAY,2/23,155/21728,0.011595124583003389,0.11484150535351798,0.07436560637048135,SMAD3/VAV3,2
FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN,FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN,3/23,453/21728,0.011694706047896379,0.11484150535351798,0.07436560637048135,SAMD9/AFF1/XAF1,3
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP,SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP,3/23,453/21728,0.011694706047896379,0.11484150535351798,0.07436560637048135,AFF1/CROT/COBLL1,3
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN,DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN,3/23,466/21728,0.012619881781430519,0.11484150535351798,0.07436560637048135,SMAD3/AFF1/ITSN2,3
OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN,OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN,1/23,12/21728,0.012631989526770249,0.11484150535351798,0.07436560637048135,SMAD3,1
REACTOME_LYSINE_CATABOLISM,REACTOME_LYSINE_CATABOLISM,1/23,12/21728,0.012631989526770249,0.11484150535351798,0.07436560637048135,PIPOX,1
REACTOME_P2Y_RECEPTORS,REACTOME_P2Y_RECEPTORS,1/23,12/21728,0.012631989526770249,0.11484150535351798,0.07436560637048135,P2RY1,1
TURJANSKI_MAPK1_AND_MAPK2_TARGETS,TURJANSKI_MAPK1_AND_MAPK2_TARGETS,1/23,12/21728,0.012631989526770249,0.11484150535351798,0.07436560637048135,SMAD3,1
WP_MAPK_AND_NFKB_SIGNALING_PATHWAYS_INHIBITED_BY_YERSINIA_YOPJ,WP_MAPK_AND_NFKB_SIGNALING_PATHWAYS_INHIBITED_BY_YERSINIA_YOPJ,1/23,12/21728,0.012631989526770249,0.11484150535351798,0.07436560637048135,IKBKB,1
MIKKELSEN_MCV6_LCP_WITH_H3K4ME3,MIKKELSEN_MCV6_LCP_WITH_H3K4ME3,2/23,163/21728,0.012761531581206801,0.11484150535351798,0.07436560637048135,XAF1/PIPOX,2
REACTOME_PROTEIN_LOCALIZATION,REACTOME_PROTEIN_LOCALIZATION,2/23,164/21728,0.01291082049398265,0.11484150535351798,0.07436560637048135,PIPOX/CROT,2
WP_CHEMOKINE_SIGNALING_PATHWAY,WP_CHEMOKINE_SIGNALING_PATHWAY,2/23,165/21728,0.013060879013424988,0.11484150535351798,0.07436560637048135,VAV3/IKBKB,2
YAMAZAKI_TCEB3_TARGETS_UP,YAMAZAKI_TCEB3_TARGETS_UP,2/23,167/21728,0.013363298285246482,0.11484150535351798,0.07436560637048135,MDFIC/COBLL1,2
GILMORE_CORE_NFKB_PATHWAY,GILMORE_CORE_NFKB_PATHWAY,1/23,13/21728,0.013677737557755809,0.11484150535351798,0.07436560637048135,IKBKB,1
NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN,NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN,1/23,13/21728,0.013677737557755809,0.11484150535351798,0.07436560637048135,IKBKB,1
REACTOME_NF_KB_ACTIVATION_THROUGH_FADD_RIP_1_PATHWAY_MEDIATED_BY_CASPASE_8_AND_10,REACTOME_NF_KB_ACTIVATION_THROUGH_FADD_RIP_1_PATHWAY_MEDIATED_BY_CASPASE_8_AND_10,1/23,13/21728,0.013677737557755809,0.11484150535351798,0.07436560637048135,IKBKB,1
REACTOME_NF_KB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL,REACTOME_NF_KB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL,1/23,13/21728,0.013677737557755809,0.11484150535351798,0.07436560637048135,IKBKB,1
REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES,REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES,1/23,13/21728,0.013677737557755809,0.11484150535351798,0.07436560637048135,IKBKB,1
WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,1/23,13/21728,0.013677737557755809,0.11484150535351798,0.07436560637048135,IKBKB,1
WP_OSTEOPONTIN_SIGNALING,WP_OSTEOPONTIN_SIGNALING,1/23,13/21728,0.013677737557755809,0.11484150535351798,0.07436560637048135,IKBKB,1
ENK_UV_RESPONSE_KERATINOCYTE_DN,ENK_UV_RESPONSE_KERATINOCYTE_DN,3/23,481/21728,0.013738742286566883,0.11484150535351798,0.07436560637048135,COG5/AFF1/ITSN2,3
MIKKELSEN_IPS_LCP_WITH_H3K4ME3,MIKKELSEN_IPS_LCP_WITH_H3K4ME3,2/23,174/21728,0.014445766952450817,0.11484150535351798,0.07436560637048135,XAF1/PIPOX,2
REACTOME_IRAK1_RECRUITS_IKK_COMPLEX,REACTOME_IRAK1_RECRUITS_IKK_COMPLEX,1/23,14/21728,0.014722426115718612,0.11484150535351798,0.07436560637048135,IKBKB,1
JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_UP,JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_UP,2/23,176/21728,0.014761847307868522,0.11484150535351798,0.07436560637048135,SMAD3/SAMD9,2
ZHENG_BOUND_BY_FOXP3,ZHENG_BOUND_BY_FOXP3,3/23,496/21728,0.014913059411317844,0.11484150535351798,0.07436560637048135,SMAD3/MDFIC/COBLL1,3
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN,CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN,2/23,179/21728,0.015241588750732527,0.11484150535351798,0.07436560637048135,MTTP/PIPOX,2
WANG_CLIM2_TARGETS_DN,WANG_CLIM2_TARGETS_DN,2/23,182/21728,0.015728036493968065,0.11484150535351798,0.07436560637048135,SAMD9/COBLL1,2
BIOCARTA_CD40_PATHWAY,BIOCARTA_CD40_PATHWAY,1/23,15/21728,0.01576605622529481,0.11484150535351798,0.07436560637048135,IKBKB,1
BIOCARTA_RELA_PATHWAY,BIOCARTA_RELA_PATHWAY,1/23,15/21728,0.01576605622529481,0.11484150535351798,0.07436560637048135,IKBKB,1
HAHTOLA_CTCL_PATHOGENESIS,HAHTOLA_CTCL_PATHOGENESIS,1/23,15/21728,0.01576605622529481,0.11484150535351798,0.07436560637048135,VAV3,1
HUMMEL_BURKITTS_LYMPHOMA_DN,HUMMEL_BURKITTS_LYMPHOMA_DN,1/23,15/21728,0.01576605622529481,0.11484150535351798,0.07436560637048135,MDFIC,1
LEE_SP4_THYMOCYTE,LEE_SP4_THYMOCYTE,1/23,15/21728,0.01576605622529481,0.11484150535351798,0.07436560637048135,P2RY1,1
REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS,REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS,1/23,15/21728,0.01576605622529481,0.11484150535351798,0.07436560637048135,PHKA1,1
REACTOME_SIGNALING_BY_ACTIVIN,REACTOME_SIGNALING_BY_ACTIVIN,1/23,15/21728,0.01576605622529481,0.11484150535351798,0.07436560637048135,SMAD3,1
TSUNODA_CISPLATIN_RESISTANCE_UP,TSUNODA_CISPLATIN_RESISTANCE_UP,1/23,15/21728,0.01576605622529481,0.11484150535351798,0.07436560637048135,VAV3,1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP,2/23,184/21728,0.016056039238547093,0.11484150535351798,0.07436560637048135,SAMD9/XAF1,2
REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING,REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING,2/23,186/21728,0.016386990405076733,0.11484150535351798,0.07436560637048135,VAV3/IKBKB,2
LEE_LIVER_CANCER_SURVIVAL_UP,LEE_LIVER_CANCER_SURVIVAL_UP,2/23,187/21728,0.016553567646335546,0.11484150535351798,0.07436560637048135,PIPOX/COBLL1,2
XIE_ST_HSC_S1PR3_OE_UP,XIE_ST_HSC_S1PR3_OE_UP,2/23,188/21728,0.016720877197405063,0.11484150535351798,0.07436560637048135,SAMD9/XAF1,2
PID_SMAD2_3PATHWAY,PID_SMAD2_3PATHWAY,1/23,16/21728,0.016808628910176093,0.11484150535351798,0.07436560637048135,SMAD3,1
REACTOME_MAP3K8_TPL2_DEPENDENT_MAPK1_3_ACTIVATION,REACTOME_MAP3K8_TPL2_DEPENDENT_MAPK1_3_ACTIVATION,1/23,16/21728,0.016808628910176093,0.11484150535351798,0.07436560637048135,IKBKB,1
REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS,REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS,1/23,16/21728,0.016808628910176093,0.11484150535351798,0.07436560637048135,P2RY1,1
REACTOME_P75NTR_SIGNALS_VIA_NF_KB,REACTOME_P75NTR_SIGNALS_VIA_NF_KB,1/23,16/21728,0.016808628910176093,0.11484150535351798,0.07436560637048135,IKBKB,1
WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,1/23,16/21728,0.016808628910176093,0.11484150535351798,0.07436560637048135,IKBKB,1
WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,1/23,16/21728,0.016808628910176093,0.11484150535351798,0.07436560637048135,SUCLG2,1
KEGG_CHEMOKINE_SIGNALING_PATHWAY,KEGG_CHEMOKINE_SIGNALING_PATHWAY,2/23,189/21728,0.0168889174645214,0.11484150535351798,0.07436560637048135,VAV3/IKBKB,2
KASLER_HDAC7_TARGETS_1_UP,KASLER_HDAC7_TARGETS_1_UP,2/23,192/21728,0.017397406658949444,0.11484150535351798,0.07436560637048135,PHKA1/OSBPL3,2
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP,2/23,194/21728,0.01774002391969688,0.11484150535351798,0.07436560637048135,SAMD9/XAF1,2
BIOCARTA_ARAP_PATHWAY,BIOCARTA_ARAP_PATHWAY,1/23,17/21728,0.017850145193110012,0.11484150535351798,0.07436560637048135,ARFGEF2,1
BIOCARTA_TNFR2_PATHWAY,BIOCARTA_TNFR2_PATHWAY,1/23,17/21728,0.017850145193110012,0.11484150535351798,0.07436560637048135,IKBKB,1
PID_NFKAPPAB_ATYPICAL_PATHWAY,PID_NFKAPPAB_ATYPICAL_PATHWAY,1/23,17/21728,0.017850145193110012,0.11484150535351798,0.07436560637048135,IKBKB,1
REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES,REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES,1/23,17/21728,0.017850145193110012,0.11484150535351798,0.07436560637048135,SMAD3,1
REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_ZBP1,REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_ZBP1,1/23,17/21728,0.017850145193110012,0.11484150535351798,0.07436560637048135,IKBKB,1
WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,1/23,17/21728,0.017850145193110012,0.11484150535351798,0.07436560637048135,SMAD3,1
WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,1/23,17/21728,0.017850145193110012,0.11484150535351798,0.07436560637048135,MTTP,1
RAMALHO_STEMNESS_UP,RAMALHO_STEMNESS_UP,2/23,197/21728,0.018259354884167897,0.11484150535351798,0.07436560637048135,MDFIC/SUCLG2,2
ZHENG_FOXP3_TARGETS_IN_THYMUS_UP,ZHENG_FOXP3_TARGETS_IN_THYMUS_UP,2/23,198/21728,0.018433900254406454,0.11484150535351798,0.07436560637048135,MDFIC/SLC25A40,2
YAMAZAKI_TCEB3_TARGETS_DN,YAMAZAKI_TCEB3_TARGETS_DN,2/23,199/21728,0.01860916052892729,0.11484150535351798,0.07436560637048135,PIPOX/SLC25A40,2
BIOCARTA_41BB_PATHWAY,BIOCARTA_41BB_PATHWAY,1/23,18/21728,0.01889060609590376,0.11484150535351798,0.07436560637048135,IKBKB,1
HASLINGER_B_CLL_WITH_MUTATED_VH_GENES,HASLINGER_B_CLL_WITH_MUTATED_VH_GENES,1/23,18/21728,0.01889060609590376,0.11484150535351798,0.07436560637048135,COBLL1,1
WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,1/23,18/21728,0.01889060609590376,0.11484150535351798,0.07436560637048135,SUCLG2,1
WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,1/23,18/21728,0.01889060609590376,0.11484150535351798,0.07436560637048135,SMAD3,1
BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP,BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP,2/23,204/21728,0.01949613064232201,0.11484150535351798,0.07436560637048135,SAMD9/XAF1,2
BIOCARTA_TGFB_PATHWAY,BIOCARTA_TGFB_PATHWAY,1/23,19/21728,0.019930012639422956,0.11484150535351798,0.07436560637048135,SMAD3,1
BIOCARTA_TID_PATHWAY,BIOCARTA_TID_PATHWAY,1/23,19/21728,0.019930012639422956,0.11484150535351798,0.07436560637048135,IKBKB,1
BIOCARTA_TOB1_PATHWAY,BIOCARTA_TOB1_PATHWAY,1/23,19/21728,0.019930012639422956,0.11484150535351798,0.07436560637048135,SMAD3,1
HUMMERICH_BENIGN_SKIN_TUMOR_DN,HUMMERICH_BENIGN_SKIN_TUMOR_DN,1/23,19/21728,0.019930012639422956,0.11484150535351798,0.07436560637048135,AFF1,1
PID_EPHA2_FWD_PATHWAY,PID_EPHA2_FWD_PATHWAY,1/23,19/21728,0.019930012639422956,0.11484150535351798,0.07436560637048135,VAV3,1
REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY,REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY,1/23,19/21728,0.019930012639422956,0.11484150535351798,0.07436560637048135,MTTP,1
REACTOME_TICAM1_RIP1_MEDIATED_IKK_COMPLEX_RECRUITMENT,REACTOME_TICAM1_RIP1_MEDIATED_IKK_COMPLEX_RECRUITMENT,1/23,19/21728,0.019930012639422956,0.11484150535351798,0.07436560637048135,IKBKB,1
FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP,FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP,1/23,20/21728,0.020968365843591297,0.11484150535351798,0.07436560637048135,SUCLG2,1
HUMMERICH_MALIGNANT_SKIN_TUMOR_DN,HUMMERICH_MALIGNANT_SKIN_TUMOR_DN,1/23,20/21728,0.020968365843591297,0.11484150535351798,0.07436560637048135,AFF1,1
LAMB_CCND1_TARGETS,LAMB_CCND1_TARGETS,1/23,20/21728,0.020968365843591297,0.11484150535351798,0.07436560637048135,SMAD3,1
REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION,REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION,1/23,20/21728,0.020968365843591297,0.11484150535351798,0.07436560637048135,SMAD3,1
CAIRO_HEPATOBLASTOMA_CLASSES_DN,CAIRO_HEPATOBLASTOMA_CLASSES_DN,2/23,214/21728,0.02132279185729403,0.11484150535351798,0.07436560637048135,SMAD3/SLC4A4,2
BIOCARTA_NFKB_PATHWAY,BIOCARTA_NFKB_PATHWAY,1/23,21/21728,0.02200566672739479,0.11484150535351798,0.07436560637048135,IKBKB,1
FINETTI_BREAST_CANCERS_KINOME_BLUE,FINETTI_BREAST_CANCERS_KINOME_BLUE,1/23,21/21728,0.02200566672739479,0.11484150535351798,0.07436560637048135,IKBKB,1
OUYANG_PROSTATE_CANCER_MARKERS,OUYANG_PROSTATE_CANCER_MARKERS,1/23,21/21728,0.02200566672739479,0.11484150535351798,0.07436560637048135,VAV3,1
REACTOME_INTERLEUKIN_37_SIGNALING,REACTOME_INTERLEUKIN_37_SIGNALING,1/23,21/21728,0.02200566672739479,0.11484150535351798,0.07436560637048135,SMAD3,1
REACTOME_ZBP1_DAI_MEDIATED_INDUCTION_OF_TYPE_I_IFNS,REACTOME_ZBP1_DAI_MEDIATED_INDUCTION_OF_TYPE_I_IFNS,1/23,21/21728,0.02200566672739479,0.11484150535351798,0.07436560637048135,IKBKB,1
WP_FOXA2_PATHWAY,WP_FOXA2_PATHWAY,1/23,21/21728,0.02200566672739479,0.11484150535351798,0.07436560637048135,MTTP,1
VANOEVELEN_MYOGENESIS_SIN3A_TARGETS,VANOEVELEN_MYOGENESIS_SIN3A_TARGETS,2/23,220/21728,0.022452011086512888,0.11484150535351798,0.07436560637048135,SUCLG2/SLC25A40,2
BIOCARTA_AKT_PATHWAY,BIOCARTA_AKT_PATHWAY,1/23,22/21728,0.023041916308877974,0.11484150535351798,0.07436560637048135,IKBKB,1
BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN,BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN,1/23,22/21728,0.023041916308877974,0.11484150535351798,0.07436560637048135,P2RY1,1
KANG_FLUOROURACIL_RESISTANCE_UP,KANG_FLUOROURACIL_RESISTANCE_UP,1/23,22/21728,0.023041916308877974,0.11484150535351798,0.07436560637048135,OSBPL3,1
NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON,NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON,1/23,22/21728,0.023041916308877974,0.11484150535351798,0.07436560637048135,TTC23,1
REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE,REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE,1/23,22/21728,0.023041916308877974,0.11484150535351798,0.07436560637048135,SUCLG2,1
SAGIV_CD24_TARGETS_UP,SAGIV_CD24_TARGETS_UP,1/23,22/21728,0.023041916308877974,0.11484150535351798,0.07436560637048135,SLC4A4,1
WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,1/23,22/21728,0.023041916308877974,0.11484150535351798,0.07436560637048135,MTTP,1
WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,1/23,22/21728,0.023041916308877974,0.11484150535351798,0.07436560637048135,IKBKB,1
WP_TYPE_II_DIABETES_MELLITUS,WP_TYPE_II_DIABETES_MELLITUS,1/23,22/21728,0.023041916308877974,0.11484150535351798,0.07436560637048135,IKBKB,1
CAIRO_LIVER_DEVELOPMENT_DN,CAIRO_LIVER_DEVELOPMENT_DN,2/23,224/21728,0.023218462548271507,0.11484150535351798,0.07436560637048135,PIPOX/CROT,2
PHONG_TNF_RESPONSE_VIA_P38_COMPLETE,PHONG_TNF_RESPONSE_VIA_P38_COMPLETE,2/23,225/21728,0.023411766321155207,0.11484150535351798,0.07436560637048135,AFF1/ITSN2,2
LINDGREN_BLADDER_CANCER_CLUSTER_3_DN,LINDGREN_BLADDER_CANCER_CLUSTER_3_DN,2/23,226/21728,0.02360574343253933,0.11484150535351798,0.07436560637048135,SMAD3/IKBKB,2
KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION,KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION,1/23,23/21728,0.024077115605151356,0.11484150535351798,0.07436560637048135,SLC4A4,1
PID_NFKAPPAB_CANONICAL_PATHWAY,PID_NFKAPPAB_CANONICAL_PATHWAY,1/23,23/21728,0.024077115605151356,0.11484150535351798,0.07436560637048135,IKBKB,1
REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1,REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1,1/23,23/21728,0.024077115605151356,0.11484150535351798,0.07436560637048135,IKBKB,1
REACTOME_SIGNALING_BY_NODAL,REACTOME_SIGNALING_BY_NODAL,1/23,23/21728,0.024077115605151356,0.11484150535351798,0.07436560637048135,SMAD3,1
WP_ESTROGEN_SIGNALING_PATHWAY,WP_ESTROGEN_SIGNALING_PATHWAY,1/23,23/21728,0.024077115605151356,0.11484150535351798,0.07436560637048135,IKBKB,1
WP_PROGERIAASSOCIATED_LIPODYSTROPHY,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,1/23,23/21728,0.024077115605151356,0.11484150535351798,0.07436560637048135,SMAD3,1
ZIRN_TRETINOIN_RESPONSE_WT1_UP,ZIRN_TRETINOIN_RESPONSE_WT1_UP,1/23,23/21728,0.024077115605151356,0.11484150535351798,0.07436560637048135,SMAD3,1
COLDREN_GEFITINIB_RESISTANCE_DN,COLDREN_GEFITINIB_RESISTANCE_DN,2/23,230/21728,0.02438835512816341,0.11556573508443446,0.07483458126701674,VAV3/COBLL1,2
BIOCARTA_STRESS_PATHWAY,BIOCARTA_STRESS_PATHWAY,1/23,24/21728,0.025111265632383306,0.11595966613680189,0.07508967128423036,IKBKB,1
PID_TOLL_ENDOGENOUS_PATHWAY,PID_TOLL_ENDOGENOUS_PATHWAY,1/23,24/21728,0.025111265632383306,0.11595966613680189,0.07508967128423036,IKBKB,1
SA_B_CELL_RECEPTOR_COMPLEXES,SA_B_CELL_RECEPTOR_COMPLEXES,1/23,24/21728,0.025111265632383306,0.11595966613680189,0.07508967128423036,VAV3,1
WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,1/23,24/21728,0.025111265632383306,0.11595966613680189,0.07508967128423036,IKBKB,1
LEE_RECENT_THYMIC_EMIGRANT,LEE_RECENT_THYMIC_EMIGRANT,2/23,237/21728,0.025783502164651438,0.11628629674363367,0.07530118090404447,VAV3/P2RY1,2
BIOCARTA_TOLL_PATHWAY,BIOCARTA_TOLL_PATHWAY,1/23,25/21728,0.026144367405810054,0.11628629674363367,0.07530118090404447,IKBKB,1
KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN,KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN,1/23,25/21728,0.026144367405810054,0.11628629674363367,0.07530118090404447,OSBPL3,1
REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_1,REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_1,1/23,25/21728,0.026144367405810054,0.11628629674363367,0.07530118090404447,P2RY1,1
REACTOME_TRAF6_MEDIATED_NF_KB_ACTIVATION,REACTOME_TRAF6_MEDIATED_NF_KB_ACTIVATION,1/23,25/21728,0.026144367405810054,0.11628629674363367,0.07530118090404447,IKBKB,1
WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,1/23,25/21728,0.026144367405810054,0.11628629674363367,0.07530118090404447,SMAD3,1
BIOCARTA_RACCYCD_PATHWAY,BIOCARTA_RACCYCD_PATHWAY,1/23,26/21728,0.027176421939730355,0.11787962560413165,0.07633294086307475,IKBKB,1
NEWMAN_ERCC6_TARGETS_UP,NEWMAN_ERCC6_TARGETS_UP,1/23,26/21728,0.027176421939730355,0.11787962560413165,0.07633294086307475,SLC25A40,1
REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING,REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING,1/23,26/21728,0.027176421939730355,0.11787962560413165,0.07633294086307475,SMAD3,1
ZHENG_FOXP3_TARGETS_UP,ZHENG_FOXP3_TARGETS_UP,1/23,26/21728,0.027176421939730355,0.11787962560413165,0.07633294086307475,COBLL1,1
IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP,IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP,1/23,27/21728,0.028207430247507825,0.11787962560413165,0.07633294086307475,COBLL1,1
REACTOME_GLYCOGEN_METABOLISM,REACTOME_GLYCOGEN_METABOLISM,1/23,27/21728,0.028207430247507825,0.11787962560413165,0.07633294086307475,PHKA1,1
REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY,REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY,1/23,27/21728,0.028207430247507825,0.11787962560413165,0.07633294086307475,VAV3,1
BIOCARTA_G1_PATHWAY,BIOCARTA_G1_PATHWAY,1/23,28/21728,0.02923739334157316,0.11787962560413165,0.07633294086307475,SMAD3,1
PID_TRAIL_PATHWAY,PID_TRAIL_PATHWAY,1/23,28/21728,0.02923739334157316,0.11787962560413165,0.07633294086307475,IKBKB,1
REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY,REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY,1/23,28/21728,0.02923739334157316,0.11787962560413165,0.07633294086307475,SMAD3,1
RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP,RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP,1/23,28/21728,0.02923739334157316,0.11787962560413165,0.07633294086307475,MDFIC,1
WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,1/23,28/21728,0.02923739334157316,0.11787962560413165,0.07633294086307475,SMAD3,1
BROWNE_HCMV_INFECTION_4HR_DN,BROWNE_HCMV_INFECTION_4HR_DN,2/23,254/21728,0.029304413680493347,0.11787962560413165,0.07633294086307475,PHKA1/SMAD3,2
BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS,BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS,1/23,29/21728,0.0302663122334228,0.11787962560413165,0.07633294086307475,XAF1,1
REACTOME_DAP12_SIGNALING,REACTOME_DAP12_SIGNALING,1/23,29/21728,0.0302663122334228,0.11787962560413165,0.07633294086307475,VAV3,1
REACTOME_PEROXISOMAL_LIPID_METABOLISM,REACTOME_PEROXISOMAL_LIPID_METABOLISM,1/23,29/21728,0.0302663122334228,0.11787962560413165,0.07633294086307475,CROT,1
VALK_AML_CLUSTER_1,VALK_AML_CLUSTER_1,1/23,29/21728,0.0302663122334228,0.11787962560413165,0.07633294086307475,COBLL1,1
REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,2/23,261/21728,0.03080756917900006,0.11787962560413165,0.07633294086307475,VAV3/P2RY1,2
LU_AGING_BRAIN_UP,LU_AGING_BRAIN_UP,2/23,263/21728,0.031242647322294332,0.11787962560413165,0.07633294086307475,SLC4A4/AFF1,2
REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_OXIDATIVE_STRESS_METABOLIC_AND_NEURONAL_GENES,REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_OXIDATIVE_STRESS_METABOLIC_AND_NEURONAL_GENES,1/23,30/21728,0.031294187933622264,0.11787962560413165,0.07633294086307475,SMAD3,1
REACTOME_TNFR1_INDUCED_NFKAPPAB_SIGNALING_PATHWAY,REACTOME_TNFR1_INDUCED_NFKAPPAB_SIGNALING_PATHWAY,1/23,30/21728,0.031294187933622264,0.11787962560413165,0.07633294086307475,IKBKB,1
TING_SILENCED_BY_DICER,TING_SILENCED_BY_DICER,1/23,30/21728,0.031294187933622264,0.11787962560413165,0.07633294086307475,SLC4A4,1
WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,1/23,30/21728,0.031294187933622264,0.11787962560413165,0.07633294086307475,SMAD3,1
WP_TLR4_SIGNALING_AND_TOLERANCE,WP_TLR4_SIGNALING_AND_TOLERANCE,1/23,30/21728,0.031294187933622264,0.11787962560413165,0.07633294086307475,IKBKB,1
BIOCARTA_IL1R_PATHWAY,BIOCARTA_IL1R_PATHWAY,1/23,31/21728,0.03232102145180504,0.11787962560413165,0.07633294086307475,IKBKB,1
KEGG_CITRATE_CYCLE_TCA_CYCLE,KEGG_CITRATE_CYCLE_TCA_CYCLE,1/23,31/21728,0.03232102145180504,0.11787962560413165,0.07633294086307475,SUCLG2,1
KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM,KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM,1/23,31/21728,0.03232102145180504,0.11787962560413165,0.07633294086307475,PIPOX,1
MOSERLE_IFNA_RESPONSE,MOSERLE_IFNA_RESPONSE,1/23,31/21728,0.03232102145180504,0.11787962560413165,0.07633294086307475,SAMD9,1
PID_AVB3_OPN_PATHWAY,PID_AVB3_OPN_PATHWAY,1/23,31/21728,0.03232102145180504,0.11787962560413165,0.07633294086307475,VAV3,1
REACTOME_DISEASES_OF_IMMUNE_SYSTEM,REACTOME_DISEASES_OF_IMMUNE_SYSTEM,1/23,31/21728,0.03232102145180504,0.11787962560413165,0.07633294086307475,IKBKB,1
VALK_AML_CLUSTER_15,VALK_AML_CLUSTER_15,1/23,31/21728,0.03232102145180504,0.11787962560413165,0.07633294086307475,SUCLG2,1
REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION,REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION,1/23,32/21728,0.03334681379667348,0.11787962560413165,0.07633294086307475,SMAD3,1
REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX,REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX,1/23,32/21728,0.03334681379667348,0.11787962560413165,0.07633294086307475,IKBKB,1
REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS,REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS,1/23,32/21728,0.03334681379667348,0.11787962560413165,0.07633294086307475,SMAD3,1
TSAI_RESPONSE_TO_RADIATION_THERAPY,TSAI_RESPONSE_TO_RADIATION_THERAPY,1/23,32/21728,0.03334681379667348,0.11787962560413165,0.07633294086307475,SMAD3,1
WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,1/23,32/21728,0.03334681379667348,0.11787962560413165,0.07633294086307475,IKBKB,1
WP_IL17_SIGNALING_PATHWAY,WP_IL17_SIGNALING_PATHWAY,1/23,32/21728,0.03334681379667348,0.11787962560413165,0.07633294086307475,IKBKB,1
WP_OVARIAN_INFERTILITY,WP_OVARIAN_INFERTILITY,1/23,32/21728,0.03334681379667348,0.11787962560413165,0.07633294086307475,SMAD3,1
WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,1/23,32/21728,0.03334681379667348,0.11787962560413165,0.07633294086307475,IKBKB,1
ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN,ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN,2/23,274/21728,0.033679426233618553,0.11787962560413165,0.07633294086307475,MTTP/CROT,2
APPEL_IMATINIB_RESPONSE,APPEL_IMATINIB_RESPONSE,1/23,33/21728,0.03437156597600055,0.11787962560413165,0.07633294086307475,OSBPL3,1
CAFFAREL_RESPONSE_TO_THC_24HR_5_UP,CAFFAREL_RESPONSE_TO_THC_24HR_5_UP,1/23,33/21728,0.03437156597600055,0.11787962560413165,0.07633294086307475,VAV3,1
KEGG_PROPANOATE_METABOLISM,KEGG_PROPANOATE_METABOLISM,1/23,33/21728,0.03437156597600055,0.11787962560413165,0.07633294086307475,SUCLG2,1
REACTOME_SIGNAL_AMPLIFICATION,REACTOME_SIGNAL_AMPLIFICATION,1/23,33/21728,0.03437156597600055,0.11787962560413165,0.07633294086307475,P2RY1,1
TANG_SENESCENCE_TP53_TARGETS_UP,TANG_SENESCENCE_TP53_TARGETS_UP,1/23,33/21728,0.03437156597600055,0.11787962560413165,0.07633294086307475,SLC4A4,1
WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,1/23,33/21728,0.03437156597600055,0.11787962560413165,0.07633294086307475,IKBKB,1
WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,1/23,33/21728,0.03437156597600055,0.11787962560413165,0.07633294086307475,IKBKB,1
WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,1/23,33/21728,0.03437156597600055,0.11787962560413165,0.07633294086307475,MTTP,1
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D,BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D,2/23,279/21728,0.034811244430724544,0.11787962560413165,0.07633294086307475,PHKA1/OSBPL3,2
PID_EPHA_FWDPATHWAY,PID_EPHA_FWDPATHWAY,1/23,34/21728,0.03539527899662975,0.11787962560413165,0.07633294086307475,VAV3,1
PID_IL1_PATHWAY,PID_IL1_PATHWAY,1/23,34/21728,0.03539527899662975,0.11787962560413165,0.07633294086307475,IKBKB,1
REACTOME_PLASMA_LIPOPROTEIN_REMODELING,REACTOME_PLASMA_LIPOPROTEIN_REMODELING,1/23,34/21728,0.03539527899662975,0.11787962560413165,0.07633294086307475,MTTP,1
REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS,REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS,1/23,34/21728,0.03539527899662975,0.11787962560413165,0.07633294086307475,OSBPL3,1
WP_PURINERGIC_SIGNALING,WP_PURINERGIC_SIGNALING,1/23,34/21728,0.03539527899662975,0.11787962560413165,0.07633294086307475,P2RY1,1
GENTILE_UV_RESPONSE_CLUSTER_D6,GENTILE_UV_RESPONSE_CLUSTER_D6,1/23,35/21728,0.03641795386447655,0.11787962560413165,0.07633294086307475,SMAD3,1
NAKAMURA_ADIPOGENESIS_LATE_DN,NAKAMURA_ADIPOGENESIS_LATE_DN,1/23,35/21728,0.03641795386447655,0.11787962560413165,0.07633294086307475,SMAD3,1
REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE,REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE,1/23,35/21728,0.03641795386447655,0.11787962560413165,0.07633294086307475,VAV3,1
REACTOME_REGULATION_OF_TNFR1_SIGNALING,REACTOME_REGULATION_OF_TNFR1_SIGNALING,1/23,35/21728,0.03641795386447655,0.11787962560413165,0.07633294086307475,IKBKB,1
WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,1/23,35/21728,0.03641795386447655,0.11787962560413165,0.07633294086307475,IKBKB,1
WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,1/23,35/21728,0.03641795386447655,0.11787962560413165,0.07633294086307475,IKBKB,1
BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_UP,BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_UP,2/23,286/21728,0.03642073949700068,0.11787962560413165,0.07633294086307475,SAMD9/XAF1,2
BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN,BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN,1/23,36/21728,0.03743959158453003,0.11853145807329377,0.07675503491933071,PHKA1,1
GUTIERREZ_MULTIPLE_MYELOMA_UP,GUTIERREZ_MULTIPLE_MYELOMA_UP,1/23,36/21728,0.03743959158453003,0.11853145807329377,0.07675503491933071,SUCLG2,1
PID_GMCSF_PATHWAY,PID_GMCSF_PATHWAY,1/23,36/21728,0.03743959158453003,0.11853145807329377,0.07675503491933071,IKBKB,1
REACTOME_NOD1_2_SIGNALING_PATHWAY,REACTOME_NOD1_2_SIGNALING_PATHWAY,1/23,36/21728,0.03743959158453003,0.11853145807329377,0.07675503491933071,IKBKB,1
SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM,SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM,1/23,36/21728,0.03743959158453003,0.11853145807329377,0.07675503491933071,PHKA1,1
RIZ_ERYTHROID_DIFFERENTIATION_HBZ,RIZ_ERYTHROID_DIFFERENTIATION_HBZ,1/23,37/21728,0.03846019316085103,0.11967227485672531,0.07749377072391941,AFF1,1
VALK_AML_WITH_CEBPA,VALK_AML_WITH_CEBPA,1/23,37/21728,0.03846019316085103,0.11967227485672531,0.07749377072391941,SUCLG2,1
WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,1/23,37/21728,0.03846019316085103,0.11967227485672531,0.07749377072391941,SMAD3,1
WP_NEOVASCULARISATION_PROCESSES,WP_NEOVASCULARISATION_PROCESSES,1/23,37/21728,0.03846019316085103,0.11967227485672531,0.07749377072391941,SMAD3,1
PID_FAS_PATHWAY,PID_FAS_PATHWAY,1/23,38/21728,0.03947975959657568,0.12026397356099734,0.0778769251661776,IKBKB,1
PID_RAC1_REG_PATHWAY,PID_RAC1_REG_PATHWAY,1/23,38/21728,0.03947975959657568,0.12026397356099734,0.0778769251661776,VAV3,1
RIZ_ERYTHROID_DIFFERENTIATION_6HR,RIZ_ERYTHROID_DIFFERENTIATION_6HR,1/23,38/21728,0.03947975959657568,0.12026397356099734,0.0778769251661776,SMAD3,1
SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN,SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN,1/23,38/21728,0.03947975959657568,0.12026397356099734,0.0778769251661776,TTC12,1
VALK_AML_CLUSTER_11,VALK_AML_CLUSTER_11,1/23,38/21728,0.03947975959657568,0.12026397356099734,0.0778769251661776,MDFIC,1
DAZARD_RESPONSE_TO_UV_NHEK_DN,DAZARD_RESPONSE_TO_UV_NHEK_DN,2/23,300/21728,0.03972529143889318,0.12050559118492701,0.07803338463662789,SMAD3/AFF1,2
REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS,REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS,1/23,39/21728,0.04049829189391441,0.12136672788008773,0.07859101362543613,ARFGEF2,1
SPIRA_SMOKERS_LUNG_CANCER_UP,SPIRA_SMOKERS_LUNG_CANCER_UP,1/23,39/21728,0.04049829189391441,0.12136672788008773,0.07859101362543613,SLC4A4,1
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP,2/23,304/21728,0.040689992770535865,0.12136672788008773,0.07859101362543613,XAF1/SLC25A40,2
BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN,BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN,1/23,40/21728,0.04151579105415415,0.12136672788008773,0.07859101362543613,PHKA1,1
KRASNOSELSKAYA_ILF3_TARGETS_UP,KRASNOSELSKAYA_ILF3_TARGETS_UP,1/23,40/21728,0.04151579105415415,0.12136672788008773,0.07859101362543613,XAF1,1
REACTOME_RHOU_GTPASE_CYCLE,REACTOME_RHOU_GTPASE_CYCLE,1/23,40/21728,0.04151579105415415,0.12136672788008773,0.07859101362543613,ITSN2,1
WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,1/23,40/21728,0.04151579105415415,0.12136672788008773,0.07859101362543613,PHKA1,1
WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,1/23,40/21728,0.04151579105415415,0.12136672788008773,0.07859101362543613,VAV3,1
ZHAN_MULTIPLE_MYELOMA_LB_DN,ZHAN_MULTIPLE_MYELOMA_LB_DN,1/23,40/21728,0.04151579105415415,0.12136672788008773,0.07859101362543613,XAF1,1
CHANGOLKAR_H2AFY_TARGETS_DN,CHANGOLKAR_H2AFY_TARGETS_DN,1/23,41/21728,0.04253225807765815,0.12334354842520863,0.07987110359004437,P2RY1,1
WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,1/23,41/21728,0.04253225807765815,0.12334354842520863,0.07987110359004437,IKBKB,1
CHANDRAN_METASTASIS_DN,CHANDRAN_METASTASIS_DN,2/23,313/21728,0.04289324315260085,0.12381207107373994,0.08017449538858515,SMAD3/P2RY1,2
BYSTROEM_CORRELATED_WITH_IL5_UP,BYSTROEM_CORRELATED_WITH_IL5_UP,1/23,42/21728,0.04354769396386715,0.12381207107373994,0.08017449538858515,IKBKB,1
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN,FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN,1/23,42/21728,0.04354769396386715,0.12381207107373994,0.08017449538858515,ITSN2,1
WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING_PATHWAY,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING_PATHWAY,1/23,42/21728,0.04354769396386715,0.12381207107373994,0.08017449538858515,IKBKB,1
ZHAN_EARLY_DIFFERENTIATION_GENES_DN,ZHAN_EARLY_DIFFERENTIATION_GENES_DN,1/23,42/21728,0.04354769396386715,0.12381207107373994,0.08017449538858515,ITSN2,1
HAHTOLA_SEZARY_SYNDROM_DN,HAHTOLA_SEZARY_SYNDROM_DN,1/23,43/21728,0.044562099711299985,0.12515992549328578,0.08104729839565222,VAV3,1
KIM_LIVER_CANCER_POOR_SURVIVAL_DN,KIM_LIVER_CANCER_POOR_SURVIVAL_DN,1/23,43/21728,0.044562099711299985,0.12515992549328578,0.08104729839565222,COBLL1,1
KEGG_LYSINE_DEGRADATION,KEGG_LYSINE_DEGRADATION,1/23,44/21728,0.0455754763175551,0.12515992549328578,0.08104729839565222,PIPOX,1
REACTOME_DAP12_INTERACTIONS,REACTOME_DAP12_INTERACTIONS,1/23,44/21728,0.0455754763175551,0.12515992549328578,0.08104729839565222,VAV3,1
REACTOME_INTRA_GOLGI_TRAFFIC,REACTOME_INTRA_GOLGI_TRAFFIC,1/23,44/21728,0.0455754763175551,0.12515992549328578,0.08104729839565222,COG5,1
REACTOME_TNF_SIGNALING,REACTOME_TNF_SIGNALING,1/23,44/21728,0.0455754763175551,0.12515992549328578,0.08104729839565222,IKBKB,1
WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING_PATHWAY,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING_PATHWAY,1/23,44/21728,0.0455754763175551,0.12515992549328578,0.08104729839565222,IKBKB,1
WP_INTERLEUKIN11_SIGNALING_PATHWAY,WP_INTERLEUKIN11_SIGNALING_PATHWAY,1/23,44/21728,0.0455754763175551,0.12515992549328578,0.08104729839565222,IKBKB,1
WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,1/23,44/21728,0.0455754763175551,0.12515992549328578,0.08104729839565222,SUCLG2,1
KEGG_PATHWAYS_IN_CANCER,KEGG_PATHWAYS_IN_CANCER,2/23,325/21728,0.04589988403740634,0.12557515444196074,0.0813161798636871,SMAD3/IKBKB,2
REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM,REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM,1/23,45/21728,0.04658782477931034,0.1260304961380597,0.0816110363376764,OSBPL3,1
WANG_TARGETS_OF_MLL_CBP_FUSION_UP,WANG_TARGETS_OF_MLL_CBP_FUSION_UP,1/23,45/21728,0.04658782477931034,0.1260304961380597,0.0816110363376764,ITSN2,1
WP_INTEGRATED_CANCER_PATHWAY,WP_INTEGRATED_CANCER_PATHWAY,1/23,45/21728,0.04658782477931034,0.1260304961380597,0.0816110363376764,SMAD3,1
BIOCARTA_KERATINOCYTE_PATHWAY,BIOCARTA_KERATINOCYTE_PATHWAY,1/23,46/21728,0.04759914609232396,0.12640798870672115,0.08185548161625793,IKBKB,1
PID_RHOA_REG_PATHWAY,PID_RHOA_REG_PATHWAY,1/23,46/21728,0.04759914609232396,0.12640798870672115,0.08185548161625793,VAV3,1
PID_TNF_PATHWAY,PID_TNF_PATHWAY,1/23,46/21728,0.04759914609232396,0.12640798870672115,0.08185548161625793,IKBKB,1
REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER,REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER,1/23,46/21728,0.04759914609232396,0.12640798870672115,0.08185548161625793,SMAD3,1
WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,1/23,46/21728,0.04759914609232396,0.12640798870672115,0.08185548161625793,SMAD3,1
KEGG_TYPE_II_DIABETES_MELLITUS,KEGG_TYPE_II_DIABETES_MELLITUS,1/23,47/21728,0.048609441251436514,0.1281521632992417,0.08298492171537107,IKBKB,1
ZHAN_MULTIPLE_MYELOMA_CD2_DN,ZHAN_MULTIPLE_MYELOMA_CD2_DN,1/23,47/21728,0.048609441251436514,0.1281521632992417,0.08298492171537107,OSBPL3,1
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP,2/23,339/21728,0.049504474932333155,0.12864185674056602,0.08330202265886384,SAMD9/XAF1,2
BROWNE_HCMV_INFECTION_8HR_DN,BROWNE_HCMV_INFECTION_8HR_DN,1/23,48/21728,0.049618711250569936,0.12864185674056602,0.08330202265886384,SMAD3,1
DAUER_STAT3_TARGETS_DN,DAUER_STAT3_TARGETS_DN,1/23,48/21728,0.049618711250569936,0.12864185674056602,0.08330202265886384,SAMD9,1
FARMER_BREAST_CANCER_CLUSTER_1,FARMER_BREAST_CANCER_CLUSTER_1,1/23,48/21728,0.049618711250569936,0.12864185674056602,0.08330202265886384,XAF1,1
PHONG_TNF_RESPONSE_NOT_VIA_P38,PHONG_TNF_RESPONSE_NOT_VIA_P38,2/23,341/21728,0.05002773696404969,0.12864185674056602,0.08330202265886384,SMAD3/CROT,2
EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN,EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN,1/23,49/21728,0.05062695708273046,0.12864185674056602,0.08330202265886384,PIPOX,1
MILI_PSEUDOPODIA,MILI_PSEUDOPODIA,1/23,49/21728,0.05062695708273046,0.12864185674056602,0.08330202265886384,XAF1,1
PID_FOXO_PATHWAY,PID_FOXO_PATHWAY,1/23,49/21728,0.05062695708273046,0.12864185674056602,0.08330202265886384,IKBKB,1
REACTOME_RETROGRADE_TRANSPORT_AT_THE_TRANS_GOLGI_NETWORK,REACTOME_RETROGRADE_TRANSPORT_AT_THE_TRANS_GOLGI_NETWORK,1/23,49/21728,0.05062695708273046,0.12864185674056602,0.08330202265886384,COG5,1
KENNY_CTNNB1_TARGETS_UP,KENNY_CTNNB1_TARGETS_UP,1/23,50/21728,0.0516341797400065,0.12864185674056602,0.08330202265886384,ARFGEF2,1
LIU_SMARCA4_TARGETS,LIU_SMARCA4_TARGETS,1/23,50/21728,0.0516341797400065,0.12864185674056602,0.08330202265886384,PIPOX,1
MARTINEZ_RESPONSE_TO_TRABECTEDIN,MARTINEZ_RESPONSE_TO_TRABECTEDIN,1/23,50/21728,0.0516341797400065,0.12864185674056602,0.08330202265886384,SMAD3,1
NOUSHMEHR_GBM_SILENCED_BY_METHYLATION,NOUSHMEHR_GBM_SILENCED_BY_METHYLATION,1/23,50/21728,0.0516341797400065,0.12864185674056602,0.08330202265886384,TTC12,1
ROY_WOUND_BLOOD_VESSEL_UP,ROY_WOUND_BLOOD_VESSEL_UP,1/23,50/21728,0.0516341797400065,0.12864185674056602,0.08330202265886384,XAF1,1
WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,1/23,50/21728,0.0516341797400065,0.12864185674056602,0.08330202265886384,SMAD3,1
WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,1/23,50/21728,0.0516341797400065,0.12864185674056602,0.08330202265886384,IKBKB,1
APPIERTO_RESPONSE_TO_FENRETINIDE_DN,APPIERTO_RESPONSE_TO_FENRETINIDE_DN,1/23,51/21728,0.05264038021357387,0.129810461411024,0.08405875250717491,ARFGEF2,1
BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN,BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN,1/23,51/21728,0.05264038021357387,0.129810461411024,0.08405875250717491,SLC4A4,1
REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS,REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS,1/23,51/21728,0.05264038021357387,0.129810461411024,0.08405875250717491,VAV3,1
LUI_THYROID_CANCER_CLUSTER_1,LUI_THYROID_CANCER_CLUSTER_1,1/23,52/21728,0.05364555949369043,0.13095296509402546,0.08479858066342705,ITSN2,1
ROSS_AML_WITH_CBFB_MYH11_FUSION,ROSS_AML_WITH_CBFB_MYH11_FUSION,1/23,52/21728,0.05364555949369043,0.13095296509402546,0.08479858066342705,MDFIC,1
WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER,WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER,1/23,52/21728,0.05364555949369043,0.13095296509402546,0.08479858066342705,SLC4A4,1
BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP,BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP,1/23,53/21728,0.05464971856970291,0.1325118594081425,0.08580804253507306,ARFGEF2,1
PID_CD8_TCR_PATHWAY,PID_CD8_TCR_PATHWAY,1/23,53/21728,0.05464971856970291,0.1325118594081425,0.08580804253507306,IKBKB,1
PID_TAP63_PATHWAY,PID_TAP63_PATHWAY,1/23,54/21728,0.05565285843004408,0.13316278007188767,0.08622954615181404,IKBKB,1
PID_TGFBR_PATHWAY,PID_TGFBR_PATHWAY,1/23,54/21728,0.05565285843004408,0.13316278007188767,0.08622954615181404,SMAD3,1
WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,1/23,54/21728,0.05565285843004408,0.13316278007188767,0.08622954615181404,VAV3,1
WP_COPPER_HOMEOSTASIS,WP_COPPER_HOMEOSTASIS,1/23,54/21728,0.05565285843004408,0.13316278007188767,0.08622954615181404,XAF1,1
KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY,KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY,1/23,55/21728,0.056654980062235016,0.13335993683480646,0.08635721499575127,IKBKB,1
REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE,REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE,1/23,55/21728,0.056654980062235016,0.13335993683480646,0.08635721499575127,SUCLG2,1
WP_IL4_SIGNALING_PATHWAY,WP_IL4_SIGNALING_PATHWAY,1/23,55/21728,0.056654980062235016,0.13335993683480646,0.08635721499575127,IKBKB,1
WP_NRP1TRIGGERED_SIGNALING_PATHWAYS_IN_PANCREATIC_CANCER,WP_NRP1TRIGGERED_SIGNALING_PATHWAYS_IN_PANCREATIC_CANCER,1/23,55/21728,0.056654980062235016,0.13335993683480646,0.08635721499575127,SMAD3,1
WP_RANKLRANK_SIGNALING_PATHWAY,WP_RANKLRANK_SIGNALING_PATHWAY,1/23,55/21728,0.056654980062235016,0.13335993683480646,0.08635721499575127,IKBKB,1
DIRMEIER_LMP1_RESPONSE_LATE_UP,DIRMEIER_LMP1_RESPONSE_LATE_UP,1/23,56/21728,0.05765608445288539,0.13390109273158696,0.08670764044760479,MDFIC,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN,1/23,56/21728,0.05765608445288539,0.13390109273158696,0.08670764044760479,XAF1,1
REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS,REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS,1/23,56/21728,0.05765608445288539,0.13390109273158696,0.08670764044760479,IKBKB,1
HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER,HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER,1/23,57/21728,0.05865617258769462,0.13390109273158696,0.08670764044760479,MDFIC,1
KEGG_ACUTE_MYELOID_LEUKEMIA,KEGG_ACUTE_MYELOID_LEUKEMIA,1/23,57/21728,0.05865617258769462,0.13390109273158696,0.08670764044760479,IKBKB,1
NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON,NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON,1/23,57/21728,0.05865617258769462,0.13390109273158696,0.08670764044760479,IKBKB,1
WP_CARDIAC_HYPERTROPHIC_RESPONSE,WP_CARDIAC_HYPERTROPHIC_RESPONSE,1/23,57/21728,0.05865617258769462,0.13390109273158696,0.08670764044760479,IKBKB,1
WP_IL1_SIGNALING_PATHWAY,WP_IL1_SIGNALING_PATHWAY,1/23,57/21728,0.05865617258769462,0.13390109273158696,0.08670764044760479,IKBKB,1
AMIT_SERUM_RESPONSE_60_MCF10A,AMIT_SERUM_RESPONSE_60_MCF10A,1/23,58/21728,0.059655245451451844,0.13390109273158696,0.08670764044760479,COBLL1,1
BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_DN,BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_DN,1/23,58/21728,0.059655245451451844,0.13390109273158696,0.08670764044760479,VAV3,1
JIANG_HYPOXIA_CANCER,JIANG_HYPOXIA_CANCER,1/23,58/21728,0.059655245451451844,0.13390109273158696,0.08670764044760479,SUCLG2,1
LIANG_SILENCED_BY_METHYLATION_2,LIANG_SILENCED_BY_METHYLATION_2,1/23,58/21728,0.059655245451451844,0.13390109273158696,0.08670764044760479,XAF1,1
LUCAS_HNF4A_TARGETS_UP,LUCAS_HNF4A_TARGETS_UP,1/23,58/21728,0.059655245451451844,0.13390109273158696,0.08670764044760479,OSBPL3,1
WP_PROXIMAL_TUBULE_TRANSPORT,WP_PROXIMAL_TUBULE_TRANSPORT,1/23,58/21728,0.059655245451451844,0.13390109273158696,0.08670764044760479,SLC4A4,1
WP_TGFBETA_RECEPTOR_SIGNALING,WP_TGFBETA_RECEPTOR_SIGNALING,1/23,58/21728,0.059655245451451844,0.13390109273158696,0.08670764044760479,SMAD3,1
BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP,BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP,2/23,378/21728,0.06006719039503508,0.13405342502740597,0.08680628321193913,SAMD9/XAF1,2
BILD_SRC_ONCOGENIC_SIGNATURE,BILD_SRC_ONCOGENIC_SIGNATURE,1/23,59/21728,0.060653304028037924,0.13405342502740597,0.08680628321193913,ZNF12,1
HUTTMANN_B_CLL_POOR_SURVIVAL_DN,HUTTMANN_B_CLL_POOR_SURVIVAL_DN,1/23,59/21728,0.060653304028037924,0.13405342502740597,0.08680628321193913,COBLL1,1
MIKKELSEN_NPC_LCP_WITH_H3K4ME3,MIKKELSEN_NPC_LCP_WITH_H3K4ME3,1/23,59/21728,0.060653304028037924,0.13405342502740597,0.08680628321193913,PIPOX,1
REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK,REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK,1/23,59/21728,0.060653304028037924,0.13405342502740597,0.08680628321193913,VAV3,1
FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP,FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP,2/23,383/21728,0.06147423137999498,0.13405342502740597,0.08680628321193913,SMAD3/VAV3,2
CHANG_IMMORTALIZED_BY_HPV31_DN,CHANG_IMMORTALIZED_BY_HPV31_DN,1/23,60/21728,0.06165034930042479,0.13405342502740597,0.08680628321193913,SAMD9,1
JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN,JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN,1/23,60/21728,0.06165034930042479,0.13405342502740597,0.08680628321193913,AFF1,1
PID_FCER1_PATHWAY,PID_FCER1_PATHWAY,1/23,60/21728,0.06165034930042479,0.13405342502740597,0.08680628321193913,IKBKB,1
WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,1/23,60/21728,0.06165034930042479,0.13405342502740597,0.08680628321193913,SMAD3,1
VECCHI_GASTRIC_CANCER_EARLY_DN,VECCHI_GASTRIC_CANCER_EARLY_DN,2/23,384/21728,0.061757026150556685,0.13405342502740597,0.08680628321193913,MDFIC/MTTP,2
STEIN_ESRRA_TARGETS_UP,STEIN_ESRRA_TARGETS_UP,2/23,385/21728,0.06204028032521443,0.13426627831576254,0.08694411633949926,AFF1/SLC25A40,2
PID_AR_PATHWAY,PID_AR_PATHWAY,1/23,61/21728,0.06264638225067853,0.1343746364844436,0.0870142836617958,VAV3,1
WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,1/23,61/21728,0.06264638225067853,0.1343746364844436,0.0870142836617958,IKBKB,1
WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_RLR_PATHWAY,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_RLR_PATHWAY,1/23,61/21728,0.06264638225067853,0.1343746364844436,0.0870142836617958,IKBKB,1
KEGG_COLORECTAL_CANCER,KEGG_COLORECTAL_CANCER,1/23,62/21728,0.0636414038599562,0.1349123327440592,0.08736246882591713,SMAD3,1
KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY,KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY,1/23,62/21728,0.0636414038599562,0.1349123327440592,0.08736246882591713,IKBKB,1
WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,1/23,62/21728,0.0636414038599562,0.1349123327440592,0.08736246882591713,IKBKB,1
WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,1/23,62/21728,0.0636414038599562,0.1349123327440592,0.08736246882591713,SMAD3,1
GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11,GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11,1/23,63/21728,0.06463541510851278,0.1354354796348895,0.08770123254760179,XAF1,1
PID_BCR_5PATHWAY,PID_BCR_5PATHWAY,1/23,63/21728,0.06463541510851278,0.1354354796348895,0.08770123254760179,IKBKB,1
PID_MYC_REPRESS_PATHWAY,PID_MYC_REPRESS_PATHWAY,1/23,63/21728,0.06463541510851278,0.1354354796348895,0.08770123254760179,SMAD3,1
WP_MIRNAS_INVOLVEMENT_IN_THE_IMMUNE_RESPONSE_IN_SEPSIS,WP_MIRNAS_INVOLVEMENT_IN_THE_IMMUNE_RESPONSE_IN_SEPSIS,1/23,63/21728,0.06463541510851278,0.1354354796348895,0.08770123254760179,IKBKB,1
BASAKI_YBX1_TARGETS_DN,BASAKI_YBX1_TARGETS_DN,2/23,395/21728,0.064897828204733915,0.13555727153099462,0.08778009887887275,VAV3/COBLL1,2
BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP,BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP,1/23,64/21728,0.06562841697569533,0.13555727153099462,0.08778009887887275,XAF1,1
DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP,DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP,1/23,64/21728,0.06562841697569533,0.13555727153099462,0.08778009887887275,VAV3,1
PID_TCR_PATHWAY,PID_TCR_PATHWAY,1/23,64/21728,0.06562841697569533,0.13555727153099462,0.08778009887887275,IKBKB,1
REACTOME_CYTOSOLIC_SENSORS_OF_PATHOGEN_ASSOCIATED_DNA,REACTOME_CYTOSOLIC_SENSORS_OF_PATHOGEN_ASSOCIATED_DNA,1/23,64/21728,0.06562841697569533,0.13555727153099462,0.08778009887887275,IKBKB,1
LEE_LIVER_CANCER_ACOX1_DN,LEE_LIVER_CANCER_ACOX1_DN,1/23,65/21728,0.06662041043994738,0.13701376763076625,0.08872325279611146,PIPOX,1
JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_DN,JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_DN,2/23,402/21728,0.06692474317641464,0.13701376763076625,0.08872325279611146,XAF1/VAV3,2
HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP,HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP,1/23,66/21728,0.0676113964788102,0.13701376763076625,0.08872325279611146,SUCLG2,1
LEE_LIVER_CANCER_CIPROFIBRATE_DN,LEE_LIVER_CANCER_CIPROFIBRATE_DN,1/23,66/21728,0.0676113964788102,0.13701376763076625,0.08872325279611146,PIPOX,1
PID_HIF1_TFPATHWAY,PID_HIF1_TFPATHWAY,1/23,66/21728,0.0676113964788102,0.13701376763076625,0.08872325279611146,SMAD3,1
REACTOME_FOXO_MEDIATED_TRANSCRIPTION,REACTOME_FOXO_MEDIATED_TRANSCRIPTION,1/23,66/21728,0.0676113964788102,0.13701376763076625,0.08872325279611146,SMAD3,1
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP,2/23,405/21728,0.06780001794809416,0.13701376763076625,0.08872325279611146,XAF1/CROT,2
REN_ALVEOLAR_RHABDOMYOSARCOMA_DN,REN_ALVEOLAR_RHABDOMYOSARCOMA_DN,2/23,407/21728,0.06838571025651237,0.13701376763076625,0.08872325279611146,SMAD3/OSBPL3,2
BROWNE_INTERFERON_RESPONSIVE_GENES,BROWNE_INTERFERON_RESPONSIVE_GENES,1/23,67/21728,0.06860137606892158,0.13701376763076625,0.08872325279611146,XAF1,1
KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY,KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY,1/23,67/21728,0.06860137606892158,0.13701376763076625,0.08872325279611146,IKBKB,1
PID_TELOMERASE_PATHWAY,PID_TELOMERASE_PATHWAY,1/23,67/21728,0.06860137606892158,0.13701376763076625,0.08872325279611146,SMAD3,1
VANHARANTA_UTERINE_FIBROID_DN,VANHARANTA_UTERINE_FIBROID_DN,1/23,67/21728,0.06860137606892158,0.13701376763076625,0.08872325279611146,MDFIC,1
YAGI_AML_WITH_INV_16_TRANSLOCATION,YAGI_AML_WITH_INV_16_TRANSLOCATION,2/23,411/21728,0.06956227530636624,0.1374741250268728,0.08902135718618553,SLC25A40/ITSN2,2
KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION,KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION,1/23,68/21728,0.069590350186017,0.1374741250268728,0.08902135718618553,IKBKB,1
PID_P75_NTR_PATHWAY,PID_P75_NTR_PATHWAY,1/23,68/21728,0.069590350186017,0.1374741250268728,0.08902135718618553,IKBKB,1
WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,1/23,68/21728,0.069590350186017,0.1374741250268728,0.08902135718618553,SMAD3,1
AKL_HTLV1_INFECTION_DN,AKL_HTLV1_INFECTION_DN,1/23,69/21728,0.07057831980493279,0.1379225926107177,0.0893117623294085,MDFIC,1
PID_MTOR_4PATHWAY,PID_MTOR_4PATHWAY,1/23,69/21728,0.07057831980493279,0.1379225926107177,0.0893117623294085,IKBKB,1
WATANABE_COLON_CANCER_MSI_VS_MSS_DN,WATANABE_COLON_CANCER_MSI_VS_MSS_DN,1/23,69/21728,0.07057831980493279,0.1379225926107177,0.0893117623294085,VAV3,1
WP_RAC1PAK1P38MMP2_PATHWAY,WP_RAC1PAK1P38MMP2_PATHWAY,1/23,69/21728,0.07057831980493279,0.1379225926107177,0.0893117623294085,IKBKB,1
HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN,HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN,1/23,70/21728,0.07156528589960476,0.13805683949140027,0.08939869388481239,COBLL1,1
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1,SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1,2/23,421/21728,0.0725334801508494,0.13805683949140027,0.08939869388481239,SMAD3/SAMD9,2
GU_PDEF_TARGETS_UP,GU_PDEF_TARGETS_UP,1/23,71/21728,0.0725512494430669,0.13805683949140027,0.08939869388481239,SMAD3,1
KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY,KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY,1/23,71/21728,0.0725512494430669,0.13805683949140027,0.08939869388481239,IKBKB,1
REACTOME_INTERFERON_ALPHA_BETA_SIGNALING,REACTOME_INTERFERON_ALPHA_BETA_SIGNALING,1/23,71/21728,0.0725512494430669,0.13805683949140027,0.08939869388481239,XAF1,1
REACTOME_INTERLEUKIN_17_SIGNALING,REACTOME_INTERLEUKIN_17_SIGNALING,1/23,71/21728,0.0725512494430669,0.13805683949140027,0.08939869388481239,IKBKB,1
REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE,REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE,1/23,71/21728,0.0725512494430669,0.13805683949140027,0.08939869388481239,MTTP,1
SATOH_COLORECTAL_CANCER_MYC_DN,SATOH_COLORECTAL_CANCER_MYC_DN,1/23,71/21728,0.0725512494430669,0.13805683949140027,0.08939869388481239,SLC4A4,1
WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,1/23,71/21728,0.0725512494430669,0.13805683949140027,0.08939869388481239,IKBKB,1
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN,ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN,1/23,71/21728,0.0725512494430669,0.13805683949140027,0.08939869388481239,SUCLG2,1
KEGG_ADHERENS_JUNCTION,KEGG_ADHERENS_JUNCTION,1/23,73/21728,0.07452017276401623,0.14108188788720633,0.0913575636990113,SMAD3,1
FOROUTAN_INTEGRATED_TGFB_EMT_DN,FOROUTAN_INTEGRATED_TGFB_EMT_DN,1/23,74/21728,0.07550313448308421,0.14108188788720633,0.0913575636990113,VAV3,1
LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP,LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP,1/23,74/21728,0.07550313448308421,0.14108188788720633,0.0913575636990113,SMAD3,1
PID_AVB3_INTEGRIN_PATHWAY,PID_AVB3_INTEGRIN_PATHWAY,1/23,74/21728,0.07550313448308421,0.14108188788720633,0.0913575636990113,VAV3,1
REACTOME_RHOG_GTPASE_CYCLE,REACTOME_RHOG_GTPASE_CYCLE,1/23,74/21728,0.07550313448308421,0.14108188788720633,0.0913575636990113,VAV3,1
WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,1/23,74/21728,0.07550313448308421,0.14108188788720633,0.0913575636990113,SMAD3,1
WP_CYTOSOLIC_DNASENSING_PATHWAY,WP_CYTOSOLIC_DNASENSING_PATHWAY,1/23,74/21728,0.07550313448308421,0.14108188788720633,0.0913575636990113,IKBKB,1
NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON,NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON,1/23,75/21728,0.07648509753410937,0.14145840742915636,0.09160137889423411,SAMD9,1
REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,1/23,75/21728,0.07648509753410937,0.14145840742915636,0.09160137889423411,SMAD3,1
SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP,SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP,1/23,75/21728,0.07648509753410937,0.14145840742915636,0.09160137889423411,SAMD9,1
TCGA_GLIOBLASTOMA_COPY_NUMBER_UP,TCGA_GLIOBLASTOMA_COPY_NUMBER_UP,1/23,75/21728,0.07648509753410937,0.14145840742915636,0.09160137889423411,SAMD9,1
REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE,REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE,1/23,76/21728,0.07746606288564073,0.1425454202844912,0.09230527397006619,VAV3,1
WP_LEPTIN_SIGNALING_PATHWAY,WP_LEPTIN_SIGNALING_PATHWAY,1/23,76/21728,0.07746606288564073,0.1425454202844912,0.09230527397006619,IKBKB,1
FRASOR_RESPONSE_TO_ESTRADIOL_DN,FRASOR_RESPONSE_TO_ESTRADIOL_DN,1/23,77/21728,0.07844603150533513,0.1435385597410655,0.0929483813350493,SMAD3,1
RODRIGUES_THYROID_CARCINOMA_DN,RODRIGUES_THYROID_CARCINOMA_DN,1/23,77/21728,0.07844603150533513,0.1435385597410655,0.0929483813350493,SAMD9,1
GRYDER_PAX3FOXO1_TOP_ENHANCERS,GRYDER_PAX3FOXO1_TOP_ENHANCERS,2/23,441/21728,0.07859973547200413,0.1435385597410655,0.0929483813350493,PIPOX/ITSN2,2
BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE,BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE,1/23,78/21728,0.0794250043599557,0.14425823257658782,0.09341440541438573,XAF1,1
CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP,CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP,1/23,79/21728,0.08040298241536992,0.14425823257658782,0.09341440541438573,CROT,1
KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY,KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY,1/23,79/21728,0.08040298241536992,0.14425823257658782,0.09341440541438573,VAV3,1
MCBRYAN_PUBERTAL_BREAST_6_7WK_DN,MCBRYAN_PUBERTAL_BREAST_6_7WK_DN,1/23,79/21728,0.08040298241536992,0.14425823257658782,0.09341440541438573,SLC4A4,1
PID_MYC_ACTIV_PATHWAY,PID_MYC_ACTIV_PATHWAY,1/23,79/21728,0.08040298241536992,0.14425823257658782,0.09341440541438573,SMAD3,1
BOYLAN_MULTIPLE_MYELOMA_D_DN,BOYLAN_MULTIPLE_MYELOMA_D_DN,1/23,80/21728,0.08137996663655533,0.14425823257658782,0.09341440541438573,PHKA1,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN,1/23,80/21728,0.08137996663655533,0.14425823257658782,0.09341440541438573,CROT,1
PID_BETA_CATENIN_NUC_PATHWAY,PID_BETA_CATENIN_NUC_PATHWAY,1/23,80/21728,0.08137996663655533,0.14425823257658782,0.09341440541438573,MDFIC,1
REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS,REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS,1/23,80/21728,0.08137996663655533,0.14425823257658782,0.09341440541438573,VAV3,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9,1/23,80/21728,0.08137996663655533,0.14425823257658782,0.09341440541438573,MDFIC,1
MOOTHA_MITOCHONDRIA,MOOTHA_MITOCHONDRIA,2/23,450/21728,0.08138154086044747,0.14425823257658782,0.09341440541438573,CROT/SLC25A40,2
REACTOME_RHO_GTPASE_CYCLE,REACTOME_RHO_GTPASE_CYCLE,2/23,450/21728,0.08138154086044747,0.14425823257658782,0.09341440541438573,VAV3/ITSN2,2
BIOCARTA_MAPK_PATHWAY,BIOCARTA_MAPK_PATHWAY,1/23,81/21728,0.08235595798759765,0.14527510837228297,0.09407288324361265,IKBKB,1
REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR,REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR,1/23,81/21728,0.08235595798759765,0.14527510837228297,0.09407288324361265,IKBKB,1
ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP,ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP,1/23,82/21728,0.08333095743169061,0.14557817864572456,0.09426913637167791,IKBKB,1
PID_SMAD2_3NUCLEAR_PATHWAY,PID_SMAD2_3NUCLEAR_PATHWAY,1/23,82/21728,0.08333095743169061,0.14557817864572456,0.09426913637167791,SMAD3,1
REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,1/23,82/21728,0.08333095743169061,0.14557817864572456,0.09426913637167791,IKBKB,1
REACTOME_SIGNALING_BY_NOTCH4,REACTOME_SIGNALING_BY_NOTCH4,1/23,82/21728,0.08333095743169061,0.14557817864572456,0.09426913637167791,SMAD3,1
SANA_TNF_SIGNALING_UP,SANA_TNF_SIGNALING_UP,1/23,83/21728,0.08430496593113979,0.14692572187518352,0.09514173786763247,SMAD3,1
KEGG_SMALL_CELL_LUNG_CANCER,KEGG_SMALL_CELL_LUNG_CANCER,1/23,84/21728,0.08527798444736023,0.1482165326132186,0.09597760224391365,IKBKB,1
REACTOME_SIGNALING_BY_INTERLEUKINS,REACTOME_SIGNALING_BY_INTERLEUKINS,2/23,463/21728,0.08545449742389707,0.1482165326132186,0.09597760224391365,SMAD3/IKBKB,2
MILI_PSEUDOPODIA_CHEMOTAXIS_UP,MILI_PSEUDOPODIA_CHEMOTAXIS_UP,1/23,85/21728,0.08625001394087817,0.14843958954041578,0.09612204273687906,XAF1,1
SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN,SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN,1/23,85/21728,0.08625001394087817,0.14843958954041578,0.09612204273687906,VAV3,1
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN,CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN,2/23,466/21728,0.08640339280265454,0.14843958954041578,0.09612204273687906,SMAD3/MDFIC,2
KEGG_TGF_BETA_SIGNALING_PATHWAY,KEGG_TGF_BETA_SIGNALING_PATHWAY,1/23,86/21728,0.08722105537133396,0.14843958954041578,0.09612204273687906,SMAD3,1
LEIN_CEREBELLUM_MARKERS,LEIN_CEREBELLUM_MARKERS,1/23,86/21728,0.08722105537133396,0.14843958954041578,0.09612204273687906,PHKA1,1
LEIN_MEDULLA_MARKERS,LEIN_MEDULLA_MARKERS,1/23,86/21728,0.08722105537133396,0.14843958954041578,0.09612204273687906,CROT,1
REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION,REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION,1/23,86/21728,0.08722105537133396,0.14843958954041578,0.09612204273687906,VAV3,1
WP_APOPTOSIS,WP_APOPTOSIS,1/23,86/21728,0.08722105537133396,0.14843958954041578,0.09612204273687906,IKBKB,1
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2,2/23,470/21728,0.08767372770346601,0.14869431286203083,0.09628698880067622,XAF1/TTC12,2
KEGG_APOPTOSIS,KEGG_APOPTOSIS,1/23,87/21728,0.08819110969748034,0.14869431286203083,0.09628698880067622,IKBKB,1
REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION,REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION,1/23,87/21728,0.08819110969748034,0.14869431286203083,0.09628698880067622,VAV3,1
WP_TCELL_ACTIVATION_SARSCOV2,WP_TCELL_ACTIVATION_SARSCOV2,1/23,87/21728,0.08819110969748034,0.14869431286203083,0.09628698880067622,IKBKB,1
BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN,BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN,1/23,88/21728,0.08916017787718367,0.14928667196526132,0.09667057088422006,SMAD3,1
HOEBEKE_LYMPHOID_STEM_CELL_DN,HOEBEKE_LYMPHOID_STEM_CELL_DN,1/23,88/21728,0.08916017787718367,0.14928667196526132,0.09667057088422006,SUCLG2,1
REACTOME_RAC2_GTPASE_CYCLE,REACTOME_RAC2_GTPASE_CYCLE,1/23,88/21728,0.08916017787718367,0.14928667196526132,0.09667057088422006,VAV3,1
KEGG_PROSTATE_CANCER,KEGG_PROSTATE_CANCER,1/23,89/21728,0.09012826086742487,0.15055988278544477,0.09749503843529347,IKBKB,1
UEDA_CENTRAL_CLOCK,UEDA_CENTRAL_CLOCK,1/23,90/21728,0.09109535962430182,0.15182559937383638,0.09831465309725015,PHKA1,1
SWEET_LUNG_CANCER_KRAS_UP,SWEET_LUNG_CANCER_KRAS_UP,2/23,482/21728,0.09151935087149136,0.15218240683906248,0.09854570373897914,MDFIC/SLC4A4,2
WP_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY,WP_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY,1/23,91/21728,0.09206147510302598,0.15238486175729188,0.09867680340290699,SMAD3,1
WP_APOPTOSIS_MODULATION_AND_SIGNALING,WP_APOPTOSIS_MODULATION_AND_SIGNALING,1/23,91/21728,0.09206147510302598,0.15238486175729188,0.09867680340290699,IKBKB,1
LEIN_PONS_MARKERS,LEIN_PONS_MARKERS,1/23,92/21728,0.09302660825792841,0.15328247951590476,0.09925805570104325,CROT,1
REACTOME_EPH_EPHRIN_SIGNALING,REACTOME_EPH_EPHRIN_SIGNALING,1/23,92/21728,0.09302660825792841,0.15328247951590476,0.09925805570104325,VAV3,1
REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,1/23,94/21728,0.09495393140917974,0.15561961033788313,0.10077146455273449,IKBKB,1
WP_TNFALPHA_SIGNALING_PATHWAY,WP_TNFALPHA_SIGNALING_PATHWAY,1/23,94/21728,0.09495393140917974,0.15561961033788313,0.10077146455273449,IKBKB,1
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5,2/23,493/21728,0.09508894810990651,0.15561961033788313,0.10077146455273449,COBLL1/IKBKB,2
GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN,GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN,1/23,95/21728,0.0959161233097795,0.15661979594502284,0.10141913465187688,VAV3,1
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_DN,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_DN,1/23,96/21728,0.0968773366950646,0.15712767137342692,0.10174800933945324,CROT,1
KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS,KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS,1/23,96/21728,0.0968773366950646,0.15712767137342692,0.10174800933945324,VAV3,1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3,1/23,96/21728,0.0968773366950646,0.15712767137342692,0.10174800933945324,SMAD3,1
RODWELL_AGING_KIDNEY_UP,RODWELL_AGING_KIDNEY_UP,2/23,500/21728,0.09738200222394246,0.15759364199187115,0.10204974857114271,SAMD9/IKBKB,2
REACTOME_MYD88_INDEPENDENT_TLR4_CASCADE,REACTOME_MYD88_INDEPENDENT_TLR4_CASCADE,1/23,97/21728,0.09783757251496228,0.15790929816393928,0.1022541516967215,IKBKB,1
IGARASHI_ATF4_TARGETS_DN,IGARASHI_ATF4_TARGETS_DN,1/23,98/21728,0.09879683171851994,0.15790929816393928,0.1022541516967215,SUCLG2,1
REACTOME_PROTEIN_FOLDING,REACTOME_PROTEIN_FOLDING,1/23,98/21728,0.09879683171851994,0.15790929816393928,0.1022541516967215,ARFGEF2,1
WP_B_CELL_RECEPTOR_SIGNALING_PATHWAY,WP_B_CELL_RECEPTOR_SIGNALING_PATHWAY,1/23,98/21728,0.09879683171851994,0.15790929816393928,0.1022541516967215,IKBKB,1
WP_SMALL_CELL_LUNG_CANCER,WP_SMALL_CELL_LUNG_CANCER,1/23,98/21728,0.09879683171851994,0.15790929816393928,0.1022541516967215,IKBKB,1
BRUINS_UVC_RESPONSE_MIDDLE,BRUINS_UVC_RESPONSE_MIDDLE,1/23,99/21728,0.09975511525390923,0.15790929816393928,0.1022541516967215,TTC23,1
REACTOME_SLC_TRANSPORTER_DISORDERS,REACTOME_SLC_TRANSPORTER_DISORDERS,1/23,99/21728,0.09975511525390923,0.15790929816393928,0.1022541516967215,SLC4A4,1
REN_ALVEOLAR_RHABDOMYOSARCOMA_UP,REN_ALVEOLAR_RHABDOMYOSARCOMA_UP,1/23,99/21728,0.09975511525390923,0.15790929816393928,0.1022541516967215,PIPOX,1
SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP,SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP,1/23,99/21728,0.09975511525390923,0.15790929816393928,0.1022541516967215,TTC12,1
WP_HIPPO_SIGNALING_REGULATION_PATHWAYS,WP_HIPPO_SIGNALING_REGULATION_PATHWAYS,1/23,99/21728,0.09975511525390923,0.15790929816393928,0.1022541516967215,SMAD3,1
DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER,DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER,1/23,100/21728,0.10071242406842507,0.15838721789502858,0.10256362857521997,COG5,1
REACTOME_CLEC7A_DECTIN_1_SIGNALING,REACTOME_CLEC7A_DECTIN_1_SIGNALING,1/23,100/21728,0.10071242406842507,0.15838721789502858,0.10256362857521997,IKBKB,1
WINZEN_DEGRADED_VIA_KHSRP,WINZEN_DEGRADED_VIA_KHSRP,1/23,100/21728,0.10071242406842507,0.15838721789502858,0.10256362857521997,SLC4A4,1
GAVIN_FOXP3_TARGETS_CLUSTER_P4,GAVIN_FOXP3_TARGETS_CLUSTER_P4,1/23,101/21728,0.10166875910848505,0.1588574361070079,0.10286811833571766,OSBPL3,1
PUJANA_BREAST_CANCER_LIT_INT_NETWORK,PUJANA_BREAST_CANCER_LIT_INT_NETWORK,1/23,101/21728,0.10166875910848505,0.1588574361070079,0.10286811833571766,SMAD3,1
WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,1/23,101/21728,0.10166875910848505,0.1588574361070079,0.10286811833571766,IKBKB,1
KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,1/23,102/21728,0.10262412131963383,0.15897967512122763,0.10294727419828317,IKBKB,1
KOBAYASHI_EGFR_SIGNALING_24HR_UP,KOBAYASHI_EGFR_SIGNALING_24HR_UP,1/23,102/21728,0.10262412131963383,0.15897967512122763,0.10294727419828317,VAV3,1
REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT,REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT,1/23,102/21728,0.10262412131963383,0.15897967512122763,0.10294727419828317,COG5,1
REACTOME_INTERLEUKIN_1_SIGNALING,REACTOME_INTERLEUKIN_1_SIGNALING,1/23,102/21728,0.10262412131963383,0.15897967512122763,0.10294727419828317,IKBKB,1
REACTOME_TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,REACTOME_TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,1/23,103/21728,0.10357851164653864,0.15977536371008622,0.1034625222717945,IKBKB,1
WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,1/23,103/21728,0.10357851164653864,0.15977536371008622,0.1034625222717945,TTC23,1
CADWELL_ATG16L1_TARGETS_UP,CADWELL_ATG16L1_TARGETS_UP,1/23,104/21728,0.10453193103299563,0.159885337550468,0.10353373582215425,MTTP,1
REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS,REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS,1/23,104/21728,0.10453193103299563,0.159885337550468,0.10353373582215425,SMAD3,1
WP_INTEGRINMEDIATED_CELL_ADHESION,WP_INTEGRINMEDIATED_CELL_ADHESION,1/23,104/21728,0.10453193103299563,0.159885337550468,0.10353373582215425,VAV3,1
WP_TOLLLIKE_RECEPTOR_SIGNALING_PATHWAY,WP_TOLLLIKE_RECEPTOR_SIGNALING_PATHWAY,1/23,104/21728,0.10453193103299563,0.159885337550468,0.10353373582215425,IKBKB,1
GHANDHI_DIRECT_IRRADIATION_UP,GHANDHI_DIRECT_IRRADIATION_UP,1/23,105/21728,0.10548438042192665,0.16066423488633785,0.10403811072131644,OSBPL3,1
REACTOME_CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,REACTOME_CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,1/23,105/21728,0.10548438042192665,0.16066423488633785,0.10403811072131644,ITSN2,1
REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION,REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION,1/23,106/21728,0.10643586075538103,0.16076249801594011,0.10410174100197357,IKBKB,1
REACTOME_SIGNALING_BY_VEGF,REACTOME_SIGNALING_BY_VEGF,1/23,106/21728,0.10643586075538103,0.16076249801594011,0.10410174100197357,VAV3,1
REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES,REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES,1/23,106/21728,0.10643586075538103,0.16076249801594011,0.10410174100197357,SLC4A4,1
WANG_HCP_PROSTATE_CANCER,WANG_HCP_PROSTATE_CANCER,1/23,106/21728,0.10643586075538103,0.16076249801594011,0.10410174100197357,AFF1,1
LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT,LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT,1/23,107/21728,0.10738637297453857,0.1618609571861548,0.10481304813796742,SAMD9,1
FOROUTAN_TGFB_EMT_DN,FOROUTAN_TGFB_EMT_DN,1/23,108/21728,0.10833591801970721,0.16261602601301806,0.10530199288828468,VAV3,1
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4,1/23,108/21728,0.10833591801970721,0.16261602601301806,0.10530199288828468,CROT,1
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP,GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP,1/23,109/21728,0.10928449683032493,0.16370095083054872,0.10600453585542613,ARFGEF2,1
WP_BURN_WOUND_HEALING,WP_BURN_WOUND_HEALING,1/23,110/21728,0.11023211034495994,0.16477995876308446,0.10670324734422604,SMAD3,1
DOANE_BREAST_CANCER_ESR1_UP,DOANE_BREAST_CANCER_ESR1_UP,1/23,111/21728,0.11117875950131417,0.16551252697834246,0.10717762182554011,VAV3,1
LIM_MAMMARY_LUMINAL_MATURE_UP,LIM_MAMMARY_LUMINAL_MATURE_UP,1/23,111/21728,0.11117875950131417,0.16551252697834246,0.10717762182554011,PHKA1,1
BROWNE_HCMV_INFECTION_12HR_UP,BROWNE_HCMV_INFECTION_12HR_UP,1/23,113/21728,0.11306916848564563,0.1676383377343417,0.10855419038768263,XAF1,1
HOSHIDA_LIVER_CANCER_SURVIVAL_DN,HOSHIDA_LIVER_CANCER_SURVIVAL_DN,1/23,113/21728,0.11306916848564563,0.1676383377343417,0.10855419038768263,SLC4A4,1
WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,1/23,114/21728,0.11401293018468928,0.16834903133177134,0.10901439996220695,SMAD3,1
WP_GASTRIN_SIGNALING_PATHWAY,WP_GASTRIN_SIGNALING_PATHWAY,1/23,114/21728,0.11401293018468928,0.16834903133177134,0.10901439996220695,IKBKB,1
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN,HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN,1/23,115/21728,0.11495573126758674,0.1690525459817452,0.10946996080995772,MDFIC,1
LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN,LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN,1/23,115/21728,0.11495573126758674,0.1690525459817452,0.10946996080995772,VAV3,1
KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION,KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION,1/23,116/21728,0.1158975726677095,0.16974897006886747,0.10992093016437735,VAV3,1
REACTOME_PARASITE_INFECTION,REACTOME_PARASITE_INFECTION,1/23,116/21728,0.1158975726677095,0.16974897006886747,0.10992093016437735,VAV3,1
GLASS_IGF2BP1_CLIP_TARGETS_KNOCKDOWN_DN,GLASS_IGF2BP1_CLIP_TARGETS_KNOCKDOWN_DN,1/23,117/21728,0.1168384553175631,0.1704383905537892,0.1103673643368276,ARFGEF2,1
WHITEFORD_PEDIATRIC_CANCER_MARKERS,WHITEFORD_PEDIATRIC_CANCER_MARKERS,1/23,117/21728,0.1168384553175631,0.1704383905537892,0.1103673643368276,SLC25A40,1
RODRIGUES_DCC_TARGETS_DN,RODRIGUES_DCC_TARGETS_DN,1/23,119/21728,0.11871734809217838,0.17283148065628376,0.11191700961553915,CROT,1
LEE_NEURAL_CREST_STEM_CELL_DN,LEE_NEURAL_CREST_STEM_CELL_DN,1/23,122/21728,0.12152851989017854,0.17621635384075887,0.11410888393898873,CROT,1
WP_CELL_CYCLE,WP_CELL_CYCLE,1/23,122/21728,0.12152851989017854,0.17621635384075887,0.11410888393898873,SMAD3,1
REACTOME_TCR_SIGNALING,REACTOME_TCR_SIGNALING,1/23,124/21728,0.12339786700856192,0.17856976762716048,0.11563283682281464,IKBKB,1
KEGG_CELL_CYCLE,KEGG_CELL_CYCLE,1/23,125/21728,0.12433111312311451,0.17956186656226697,0.11627527039821574,SMAD3,1
CHEBOTAEV_GR_TARGETS_DN,CHEBOTAEV_GR_TARGETS_DN,1/23,126/21728,0.12526340884121745,0.17983360675224286,0.1164512357335758,VAV3,1
EPPERT_HSC_R,EPPERT_HSC_R,1/23,126/21728,0.12526340884121745,0.17983360675224286,0.1164512357335758,ITSN2,1
KEGG_NEUROTROPHIN_SIGNALING_PATHWAY,KEGG_NEUROTROPHIN_SIGNALING_PATHWAY,1/23,126/21728,0.12526340884121745,0.17983360675224286,0.1164512357335758,IKBKB,1
MIKKELSEN_MEF_LCP_WITH_H3K4ME3,MIKKELSEN_MEF_LCP_WITH_H3K4ME3,1/23,129/21728,0.12805460285165537,0.1834774447973323,0.11881080272901666,XAF1,1
BROWN_MYELOID_CELL_DEVELOPMENT_DN,BROWN_MYELOID_CELL_DEVELOPMENT_DN,1/23,131/21728,0.12991066379193283,0.1850397470513778,0.1198224714118541,OSBPL3,1
MCBRYAN_PUBERTAL_BREAST_5_6WK_DN,MCBRYAN_PUBERTAL_BREAST_5_6WK_DN,1/23,131/21728,0.12991066379193283,0.1850397470513778,0.1198224714118541,ITSN2,1
WP_ADIPOGENESIS,WP_ADIPOGENESIS,1/23,131/21728,0.12991066379193283,0.1850397470513778,0.1198224714118541,SMAD3,1
NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON,NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON,1/23,133/21728,0.13176294526815524,0.18694351334523004,0.12105525510268257,PIPOX,1
WP_TGFBETA_SIGNALING_PATHWAY,WP_TGFBETA_SIGNALING_PATHWAY,1/23,133/21728,0.13176294526815524,0.18694351334523004,0.12105525510268257,SMAD3,1
REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION,REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION,1/23,136/21728,0.13453429705504083,0.1905026667283293,0.12335998455293631,IKBKB,1
BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP,BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP,1/23,137/21728,0.13545619920249075,0.19069076586758407,0.12348178813349184,XAF1,1
KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY,KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY,1/23,137/21728,0.13545619920249075,0.19069076586758407,0.12348178813349184,VAV3,1
ZHANG_BREAST_CANCER_PROGENITORS_DN,ZHANG_BREAST_CANCER_PROGENITORS_DN,1/23,137/21728,0.13545619920249075,0.19069076586758407,0.12348178813349184,MDFIC,1
EPPERT_PROGENITOR,EPPERT_PROGENITOR,1/23,138/21728,0.1363771619841283,0.19124456951352617,0.12384040363416722,P2RY1,1
WP_MEASLES_VIRUS_INFECTION,WP_MEASLES_VIRUS_INFECTION,1/23,138/21728,0.1363771619841283,0.19124456951352617,0.12384040363416722,IKBKB,1
HOELZEL_NF1_TARGETS_UP,HOELZEL_NF1_TARGETS_UP,1/23,140/21728,0.1382162731039035,0.19270538076986543,0.12478635183064975,OSBPL3,1
HOLLERN_EMT_BREAST_TUMOR_UP,HOLLERN_EMT_BREAST_TUMOR_UP,1/23,140/21728,0.1382162731039035,0.19270538076986543,0.12478635183064975,PHKA1,1
REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS,REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS,1/23,140/21728,0.1382162731039035,0.19270538076986543,0.12478635183064975,IKBKB,1
MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_UP,MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_UP,1/23,143/21728,0.14096791735486625,0.1953364433888956,0.12649009619084928,XAF1,1
REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS,REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS,1/23,143/21728,0.14096791735486625,0.1953364433888956,0.12649009619084928,VAV3,1
WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,1/23,144/21728,0.14188326309963506,0.1953364433888956,0.12649009619084928,SMAD3,1
BROWNE_HCMV_INFECTION_24HR_DN,BROWNE_HCMV_INFECTION_24HR_DN,1/23,145/21728,0.14279767585670988,0.1953364433888956,0.12649009619084928,SUCLG2,1
BROWNE_HCMV_INFECTION_30MIN_DN,BROWNE_HCMV_INFECTION_30MIN_DN,1/23,145/21728,0.14279767585670988,0.1953364433888956,0.12649009619084928,ITSN2,1
DAZARD_UV_RESPONSE_CLUSTER_G6,DAZARD_UV_RESPONSE_CLUSTER_G6,1/23,145/21728,0.14279767585670988,0.1953364433888956,0.12649009619084928,SMAD3,1
JOHNSTONE_PARVB_TARGETS_2_UP,JOHNSTONE_PARVB_TARGETS_2_UP,1/23,145/21728,0.14279767585670988,0.1953364433888956,0.12649009619084928,SMAD3,1
MIKKELSEN_ES_LCP_WITH_H3K4ME3,MIKKELSEN_ES_LCP_WITH_H3K4ME3,1/23,145/21728,0.14279767585670988,0.1953364433888956,0.12649009619084928,PIPOX,1
REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS,REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS,1/23,145/21728,0.14279767585670988,0.1953364433888956,0.12649009619084928,ITSN2,1
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN,SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN,1/23,145/21728,0.14279767585670988,0.1953364433888956,0.12649009619084928,VAV3,1
BASSO_B_LYMPHOCYTE_NETWORK,BASSO_B_LYMPHOCYTE_NETWORK,1/23,146/21728,0.14371115653387712,0.19584697084034006,0.1268206881957048,MDFIC,1
VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN,VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN,1/23,146/21728,0.14371115653387712,0.19584697084034006,0.1268206881957048,SLC4A4,1
LEE_NEURAL_CREST_STEM_CELL_UP,LEE_NEURAL_CREST_STEM_CELL_UP,1/23,147/21728,0.14462370603808106,0.19672080089607646,0.127386536769002,COBLL1,1
RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP,RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP,1/23,148/21728,0.1455353252754249,0.1975900951773091,0.12794944820193085,SMAD3,1
NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON,NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON,1/23,149/21728,0.14644601515117417,0.1980846287026143,0.12826968334136624,ARFGEF2,1
REACTOME_RHOA_GTPASE_CYCLE,REACTOME_RHOA_GTPASE_CYCLE,1/23,149/21728,0.14644601515117417,0.1980846287026143,0.12826968334136624,VAV3,1
DARWICHE_PAPILLOMA_RISK_HIGH_UP,DARWICHE_PAPILLOMA_RISK_HIGH_UP,1/23,150/21728,0.1473557765697534,0.19820582191664418,0.1283481619961137,SUCLG2,1
DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP,DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP,1/23,150/21728,0.1473557765697534,0.19820582191664418,0.1283481619961137,SUCLG2,1
TSAI_RESPONSE_TO_IONIZING_RADIATION,TSAI_RESPONSE_TO_IONIZING_RADIATION,1/23,150/21728,0.1473557765697534,0.19820582191664418,0.1283481619961137,SMAD3,1
KEGG_WNT_SIGNALING_PATHWAY,KEGG_WNT_SIGNALING_PATHWAY,1/23,151/21728,0.14826461043474992,0.19905896771332166,0.12890061647933426,SMAD3,1
HUANG_GATA2_TARGETS_UP,HUANG_GATA2_TARGETS_UP,1/23,152/21728,0.14917251764891326,0.19990771773652888,0.12945022447984306,AFF1,1
REACTOME_METABOLISM_OF_STEROIDS,REACTOME_METABOLISM_OF_STEROIDS,1/23,153/21728,0.15007949911415586,0.20038238832000552,0.12975759737309978,OSBPL3,1
WILCOX_RESPONSE_TO_PROGESTERONE_UP,WILCOX_RESPONSE_TO_PROGESTERONE_UP,1/23,153/21728,0.15007949911415586,0.20038238832000552,0.12975759737309978,SAMD9,1
WP_OREXIN_RECEPTOR_PATHWAY,WP_OREXIN_RECEPTOR_PATHWAY,1/23,154/21728,0.15098555573155437,0.20122155864958993,0.1303010020438724,OSBPL3,1
REACTOME_CDC42_GTPASE_CYCLE,REACTOME_CDC42_GTPASE_CYCLE,1/23,155/21728,0.15189068840135,0.20131764002007085,0.1303632195266085,VAV3,1
REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1/23,155/21728,0.15189068840135,0.20131764002007085,0.1303632195266085,COG5,1
REACTOME_TOLL_LIKE_RECEPTOR_CASCADES,REACTOME_TOLL_LIKE_RECEPTOR_CASCADES,1/23,155/21728,0.15189068840135,0.20131764002007085,0.1303632195266085,IKBKB,1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP,1/23,156/21728,0.15279489802294965,0.20214653479313593,0.1308999702616895,XAF1,1
GROSS_HYPOXIA_VIA_ELK3_DN,GROSS_HYPOXIA_VIA_ELK3_DN,1/23,157/21728,0.15369818549492587,0.20297119213810794,0.13143397705059334,AFF1,1
WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,1/23,160/21728,0.15640252398635024,0.20616696343655258,0.13350339846490378,IKBKB,1
WP_INSULIN_SIGNALING,WP_INSULIN_SIGNALING,1/23,161/21728,0.15730213182890895,0.20697648924856443,0.13402760683101234,IKBKB,1
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN,PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN,1/23,162/21728,0.15820082200222607,0.20778187672393822,0.1345491354176065,SMAD3,1
WP_EGFEGFR_SIGNALING_PATHWAY,WP_EGFEGFR_SIGNALING_PATHWAY,1/23,163/21728,0.15909859539988735,0.20787939670809874,0.13461228447450024,VAV3,1
BROWNE_HCMV_INFECTION_6HR_DN,BROWNE_HCMV_INFECTION_6HR_DN,1/23,164/21728,0.159995452914647,0.20787939670809874,0.13461228447450024,SMAD3,1
DARWICHE_PAPILLOMA_RISK_LOW_UP,DARWICHE_PAPILLOMA_RISK_LOW_UP,1/23,164/21728,0.159995452914647,0.20787939670809874,0.13461228447450024,SUCLG2,1
FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP,FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP,1/23,164/21728,0.159995452914647,0.20787939670809874,0.13461228447450024,IKBKB,1
PHONG_TNF_RESPONSE_VIA_P38_PARTIAL,PHONG_TNF_RESPONSE_VIA_P38_PARTIAL,1/23,164/21728,0.159995452914647,0.20787939670809874,0.13461228447450024,SMAD3,1
WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,1/23,164/21728,0.159995452914647,0.20787939670809874,0.13461228447450024,SMAD3,1
REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR,REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR,1/23,166/21728,0.16178642386235165,0.20983033506297843,0.13587561442916646,IKBKB,1
FOSTER_TOLERANT_MACROPHAGE_UP,FOSTER_TOLERANT_MACROPHAGE_UP,1/23,167/21728,0.16268053907667146,0.20986368475193382,0.13589721001722324,XAF1,1
KIM_WT1_TARGETS_12HR_UP,KIM_WT1_TARGETS_12HR_UP,1/23,167/21728,0.16268053907667146,0.20986368475193382,0.13589721001722324,SMAD3,1
KIM_WT1_TARGETS_8HR_UP,KIM_WT1_TARGETS_8HR_UP,1/23,167/21728,0.16268053907667146,0.20986368475193382,0.13589721001722324,AFF1,1
SMIRNOV_RESPONSE_TO_IR_6HR_UP,SMIRNOV_RESPONSE_TO_IR_6HR_UP,1/23,168/21728,0.1635737419708434,0.21064114196955855,0.1364006523679465,CROT,1
OHGUCHI_LIVER_HNF4A_TARGETS_DN,OHGUCHI_LIVER_HNF4A_TARGETS_DN,1/23,169/21728,0.16446603343349053,0.2106676223308845,0.1364177997235202,MTTP,1
SERVITJA_ISLET_HNF1A_TARGETS_UP,SERVITJA_ISLET_HNF1A_TARGETS_UP,1/23,169/21728,0.16446603343349053,0.2106676223308845,0.1364177997235202,SMAD3,1
SMID_BREAST_CANCER_LUMINAL_B_UP,SMID_BREAST_CANCER_LUMINAL_B_UP,1/23,169/21728,0.16446603343349053,0.2106676223308845,0.1364177997235202,TTC12,1
FIGUEROA_AML_METHYLATION_CLUSTER_3_UP,FIGUEROA_AML_METHYLATION_CLUSTER_3_UP,1/23,170/21728,0.16535741435241225,0.21143584727601214,0.13691526371702567,SMAD3,1
BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP,BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP,1/23,173/21728,0.168026102712465,0.21409301312220935,0.13863591121960853,SAMD9,1
HOLLERN_SQUAMOUS_BREAST_TUMOR,HOLLERN_SQUAMOUS_BREAST_TUMOR,1/23,173/21728,0.168026102712465,0.21409301312220935,0.13863591121960853,VAV3,1
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP,CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP,1/23,175/21728,0.1698006918064936,0.21559632497321865,0.13960938067231296,SLC4A4,1
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN,1/23,175/21728,0.1698006918064936,0.21559632497321865,0.13960938067231296,SLC4A4,1
REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,1/23,177/21728,0.17157165996289658,0.21706674754465674,0.1405615526750155,SLC4A4,1
REACTOME_FATTY_ACID_METABOLISM,REACTOME_FATTY_ACID_METABOLISM,1/23,177/21728,0.17157165996289658,0.21706674754465674,0.1405615526750155,CROT,1
KEGG_CALCIUM_SIGNALING_PATHWAY,KEGG_CALCIUM_SIGNALING_PATHWAY,1/23,178/21728,0.1724557883940997,0.21706674754465674,0.1405615526750155,PHKA1,1
REACTOME_THE_CITRIC_ACID_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT,REACTOME_THE_CITRIC_ACID_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT,1/23,178/21728,0.1724557883940997,0.21706674754465674,0.1405615526750155,SUCLG2,1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP,1/23,178/21728,0.1724557883940997,0.21706674754465674,0.1405615526750155,XAF1,1
BENPORATH_NOS_TARGETS,BENPORATH_NOS_TARGETS,1/23,179/21728,0.17333901423479248,0.21742350401422933,0.14079257029451367,PIPOX,1
MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_UP,MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_UP,1/23,179/21728,0.17333901423479248,0.21742350401422933,0.14079257029451367,XAF1,1
OKUMURA_INFLAMMATORY_RESPONSE_LPS,OKUMURA_INFLAMMATORY_RESPONSE_LPS,1/23,182/21728,0.1759832850056856,0.22035903562888093,0.14269347352519918,SMAD3,1
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN,GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN,1/23,184/21728,0.1777416353378899,0.22179463962129117,0.14362309876021181,ITSN2,1
REACTOME_RAC1_GTPASE_CYCLE,REACTOME_RAC1_GTPASE_CYCLE,1/23,184/21728,0.1777416353378899,0.22179463962129117,0.14362309876021181,VAV3,1
WP_RAS_SIGNALING,WP_RAS_SIGNALING,1/23,185/21728,0.17861946407847773,0.22250706435892845,0.14408442933442048,IKBKB,1
ALCALAY_AML_BY_NPM1_LOCALIZATION_DN,ALCALAY_AML_BY_NPM1_LOCALIZATION_DN,1/23,186/21728,0.17949639636860426,0.2228337112452707,0.14429594949603014,MDFIC,1
REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,1/23,186/21728,0.17949639636860426,0.2228337112452707,0.14429594949603014,COG5,1
BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_DN,BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_DN,1/23,187/21728,0.18037243308216488,0.22315702045148386,0.14450530834317507,VAV3,1
JISON_SICKLE_CELL_DISEASE_DN,JISON_SICKLE_CELL_DISEASE_DN,1/23,187/21728,0.18037243308216488,0.22315702045148386,0.14450530834317507,COBLL1,1
DARWICHE_SKIN_TUMOR_PROMOTER_DN,DARWICHE_SKIN_TUMOR_PROMOTER_DN,1/23,189/21728,0.1821218232711146,0.22493751596517558,0.14565826805149668,SUCLG2,1
IVANOVA_HEMATOPOIESIS_STEM_CELL,IVANOVA_HEMATOPOIESIS_STEM_CELL,1/23,190/21728,0.18299517849024116,0.22563181021330758,0.14610785822887143,COBLL1,1
SHEPARD_CRASH_AND_BURN_MUTANT_DN,SHEPARD_CRASH_AND_BURN_MUTANT_DN,1/23,191/21728,0.1838676416202777,0.22632264885348272,0.1465552107276273,SMAD3,1
YAGI_AML_FAB_MARKERS,YAGI_AML_FAB_MARKERS,1/23,194/21728,0.1864796871702673,0.2291487681329556,0.14838526401059632,ITSN2,1
MCBRYAN_PUBERTAL_BREAST_6_7WK_UP,MCBRYAN_PUBERTAL_BREAST_6_7WK_UP,1/23,195/21728,0.18734859063432818,0.22982695128576638,0.14882442144965782,ITSN2,1
KEGG_FOCAL_ADHESION,KEGG_FOCAL_ADHESION,1/23,199/21728,0.19081533566537479,0.2336843215496566,0.15132226121400633,VAV3,1
GRUETZMANN_PANCREATIC_CANCER_DN,GRUETZMANN_PANCREATIC_CANCER_DN,1/23,200/21728,0.1916798090398789,0.23434715270474235,0.1517514774683341,ITSN2,1
KIM_MYC_AMPLIFICATION_TARGETS_UP,KIM_MYC_AMPLIFICATION_TARGETS_UP,1/23,202/21728,0.19340610636999578,0.23513230506693733,0.15225990280922552,PHKA1,1
STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP,STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP,1/23,202/21728,0.19340610636999578,0.23513230506693733,0.15225990280922552,SLC4A4,1
WP_FOCAL_ADHESION,WP_FOCAL_ADHESION,1/23,202/21728,0.19340610636999578,0.23513230506693733,0.15225990280922552,VAV3,1
HAMAI_APOPTOSIS_VIA_TRAIL_DN,HAMAI_APOPTOSIS_VIA_TRAIL_DN,1/23,203/21728,0.19426793204840753,0.23513230506693733,0.15225990280922552,VAV3,1
REACTOME_INTERFERON_SIGNALING,REACTOME_INTERFERON_SIGNALING,1/23,203/21728,0.19426793204840753,0.23513230506693733,0.15225990280922552,XAF1,1
REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,1/23,203/21728,0.19426793204840753,0.23513230506693733,0.15225990280922552,COG5,1
PEREZ_TP53_AND_TP63_TARGETS,PEREZ_TP53_AND_TP63_TARGETS,1/23,207/21728,0.1977064349130705,0.2384977792212581,0.15443921529245902,ITSN2,1
WP_CIRCADIAN_RHYTHM_GENES,WP_CIRCADIAN_RHYTHM_GENES,1/23,207/21728,0.1977064349130705,0.2384977792212581,0.15443921529245902,MTTP,1
WANG_TUMOR_INVASIVENESS_DN,WANG_TUMOR_INVASIVENESS_DN,1/23,211/21728,0.20113089918439087,0.24222575067887603,0.15685326287154808,MDFIC,1
KEGG_REGULATION_OF_ACTIN_CYTOSKELETON,KEGG_REGULATION_OF_ACTIN_CYTOSKELETON,1/23,213/21728,0.20283788395584523,0.24387639447427495,0.15792213711147246,VAV3,1
TIEN_INTESTINE_PROBIOTICS_24HR_DN,TIEN_INTESTINE_PROBIOTICS_24HR_DN,1/23,215/21728,0.20454137958349594,0.24531972042005512,0.15885676269668908,COG5,1
BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_DN,BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_DN,1/23,216/21728,0.2053918210965151,0.24531972042005512,0.15885676269668908,VAV3,1
KIM_WT1_TARGETS_UP,KIM_WT1_TARGETS_UP,1/23,216/21728,0.2053918210965151,0.24531972042005512,0.15885676269668908,SMAD3,1
REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS,REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS,1/23,216/21728,0.2053918210965151,0.24531972042005512,0.15885676269668908,P2RY1,1
BOQUEST_STEM_CELL_DN,BOQUEST_STEM_CELL_DN,1/23,218/21728,0.20709009577025683,0.2465358282979248,0.15964425324264897,XAF1,1
BROWNE_HCMV_INFECTION_1HR_DN,BROWNE_HCMV_INFECTION_1HR_DN,1/23,218/21728,0.20709009577025683,0.2465358282979248,0.15964425324264897,PHKA1,1
GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP,GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP,1/23,219/21728,0.2079379306283361,0.24673486040187179,0.15977313646349886,IKBKB,1
REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES,REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES,1/23,219/21728,0.2079379306283361,0.24673486040187179,0.15977313646349886,SMAD3,1
RIGGINS_TAMOXIFEN_RESISTANCE_DN,RIGGINS_TAMOXIFEN_RESISTANCE_DN,1/23,221/21728,0.2096309996243858,0.2483373770060126,0.16081084594509132,VAV3,1
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP,ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP,1/23,223/21728,0.2113206066343991,0.2499305706524296,0.16184251834625574,SMAD3,1
BROWNE_HCMV_INFECTION_16HR_UP,BROWNE_HCMV_INFECTION_16HR_UP,1/23,224/21728,0.21216411400698254,0.25051951572485726,0.16222388967446297,ARFGEF2,1
MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_DN,MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_DN,1/23,228/21728,0.21552952228844746,0.25407951814491775,0.1645291689185239,COBLL1,1
RAO_BOUND_BY_SALL4,RAO_BOUND_BY_SALL4,1/23,229/21728,0.2163687232646041,0.2546547473487629,0.1649016585372752,SLC25A40,1
ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF,ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF,1/23,232/21728,0.218881177004429,0.2571942517475057,0.16654611438023603,AFF1,1
DELYS_THYROID_CANCER_DN,DELYS_THYROID_CANCER_DN,1/23,233/21728,0.21971694798176866,0.25775855548023024,0.16691152921115457,SLC4A4,1
BROWNE_HCMV_INFECTION_20HR_UP,BROWNE_HCMV_INFECTION_20HR_UP,1/23,236/21728,0.2222191318173362,0.26027281190237284,0.16853963572915903,XAF1,1
RUTELLA_RESPONSE_TO_HGF_DN,RUTELLA_RESPONSE_TO_HGF_DN,1/23,240/21728,0.22554344019013606,0.26374031312556234,0.17078501583158015,SMAD3,1
DOANE_RESPONSE_TO_ANDROGEN_DN,DOANE_RESPONSE_TO_ANDROGEN_DN,1/23,243/21728,0.22802774804263104,0.26621596993704916,0.17238812717520716,SMAD3,1
BLUM_RESPONSE_TO_SALIRASIB_UP,BLUM_RESPONSE_TO_SALIRASIB_UP,1/23,245/21728,0.22967971647559382,0.2672837792051453,0.17307958696986545,COG5,1
REACTOME_SIGNALING_BY_NOTCH,REACTOME_SIGNALING_BY_NOTCH,1/23,245/21728,0.22967971647559382,0.2672837792051453,0.17307958696986545,SMAD3,1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP,GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP,1/23,247/21728,0.23132830319313813,0.2687708650881813,0.17404254929848115,COG5,1
HSIAO_LIVER_SPECIFIC_GENES,HSIAO_LIVER_SPECIFIC_GENES,1/23,249/21728,0.23297351480386275,0.2693872380108461,0.1744416815286205,MTTP,1
REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,1/23,249/21728,0.23297351480386275,0.2693872380108461,0.1744416815286205,SLC4A4,1
WP_MAPK_SIGNALING_PATHWAY,WP_MAPK_SIGNALING_PATHWAY,1/23,249/21728,0.23297351480386275,0.2693872380108461,0.1744416815286205,IKBKB,1
VERHAAK_AML_WITH_NPM1_MUTATED_DN,VERHAAK_AML_WITH_NPM1_MUTATED_DN,1/23,250/21728,0.233794857005991,0.2699064830085087,0.17477791857973854,MDFIC,1
DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP,DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP,1/23,258/21728,0.24033537668065685,0.27657642554520034,0.17909703926411524,VAV3,1
WP_GPCRS_CLASS_A_RHODOPSINLIKE,WP_GPCRS_CLASS_A_RHODOPSINLIKE,1/23,258/21728,0.24033537668065685,0.27657642554520034,0.17909703926411524,P2RY1,1
KAAB_HEART_ATRIUM_VS_VENTRICLE_DN,KAAB_HEART_ATRIUM_VS_VENTRICLE_DN,1/23,262/21728,0.24358557643752232,0.2798724927372483,0.18123140727522724,PHKA1,1
AFFAR_YY1_TARGETS_DN,AFFAR_YY1_TARGETS_DN,1/23,263/21728,0.24439604563261885,0.28035938779058334,0.1815466961228315,SLC4A4,1
DURCHDEWALD_SKIN_CARCINOGENESIS_DN,DURCHDEWALD_SKIN_CARCINOGENESIS_DN,1/23,265/21728,0.24601449282681842,0.2804410492129612,0.18159957596948204,COBLL1,1
FOSTER_KDM1A_TARGETS_UP,FOSTER_KDM1A_TARGETS_UP,1/23,265/21728,0.24601449282681842,0.2804410492129612,0.18159957596948204,MDFIC,1
MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP,MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP,1/23,265/21728,0.24601449282681842,0.2804410492129612,0.18159957596948204,PHKA1,1
RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN,RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN,1/23,265/21728,0.24601449282681842,0.2804410492129612,0.18159957596948204,SMAD3,1
WP_ALZHEIMERS_DISEASE,WP_ALZHEIMERS_DISEASE,1/23,266/21728,0.24682247245058853,0.2809203964312036,0.18190997721715693,IKBKB,1
CAIRO_HEPATOBLASTOMA_DN,CAIRO_HEPATOBLASTOMA_DN,1/23,267/21728,0.24762962384065612,0.2809569284577084,0.18193363352760505,SUCLG2,1
KEGG_MAPK_SIGNALING_PATHWAY,KEGG_MAPK_SIGNALING_PATHWAY,1/23,267/21728,0.24762962384065612,0.2809569284577084,0.18193363352760505,IKBKB,1
HOLLMANN_APOPTOSIS_VIA_CD40_DN,HOLLMANN_APOPTOSIS_VIA_CD40_DN,1/23,268/21728,0.24843594780746414,0.2809922966621084,0.18195653620515484,SUCLG2,1
WANG_CLIM2_TARGETS_UP,WANG_CLIM2_TARGETS_UP,1/23,268/21728,0.24843594780746414,0.2809922966621084,0.18195653620515484,SLC25A40,1
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP,1/23,271/21728,0.2508499632614285,0.2832807217516132,0.18343840566420255,TTC23,1
KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION,KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION,1/23,272/21728,0.2516529856245261,0.28330499158040595,0.18345412158963495,P2RY1,1
MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN,MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN,1/23,272/21728,0.2516529856245261,0.28330499158040595,0.18345412158963495,ARFGEF2,1
FORTSCHEGGER_PHF8_TARGETS_UP,FORTSCHEGGER_PHF8_TARGETS_UP,1/23,278/21728,0.25645385695442613,0.28826208727435493,0.18666408845642443,VAV3,1
WP_IL18_SIGNALING_PATHWAY,WP_IL18_SIGNALING_PATHWAY,1/23,279/21728,0.25725113253904386,0.28871063636347805,0.18695454637838288,IKBKB,1
MULLIGHAN_MLL_SIGNATURE_2_DN,MULLIGHAN_MLL_SIGNATURE_2_DN,1/23,280/21728,0.25804759036698943,0.28915688255960953,0.1872435130621936,VAV3,1
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN,HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN,1/23,282/21728,0.2596380559548196,0.2904901089000682,0.18810684365797525,SUCLG2,1
HUTTMANN_B_CLL_POOR_SURVIVAL_UP,HUTTMANN_B_CLL_POOR_SURVIVAL_UP,1/23,286/21728,0.2628092092301505,0.29358501801519127,0.1901109517746284,PIPOX,1
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4,1/23,287/21728,0.263599965138541,0.2940153457314496,0.1903896104482418,SUCLG2,1
GENTILE_UV_HIGH_DOSE_DN,GENTILE_UV_HIGH_DOSE_DN,1/23,289/21728,0.2651790436336323,0.29532228361656443,0.19123591795715103,SMAD3,1
BENPORATH_OCT4_TARGETS,BENPORATH_OCT4_TARGETS,1/23,290/21728,0.2659673678090334,0.29574592279378714,0.19151024546791884,PIPOX,1
BROWNE_HCMV_INFECTION_14HR_DN,BROWNE_HCMV_INFECTION_14HR_DN,1/23,291/21728,0.2667548829942368,0.296167366264658,0.19178315114923775,SMAD3,1
REACTOME_METABOLISM_OF_CARBOHYDRATES,REACTOME_METABOLISM_OF_CARBOHYDRATES,1/23,293/21728,0.26832748956330577,0.2974578439348573,0.19261879984747207,PHKA1,1
REACTOME_DEUBIQUITINATION,REACTOME_DEUBIQUITINATION,1/23,297/21728,0.27146302963950963,0.30047434578419,0.1945721353462777,SMAD3,1
SABATES_COLORECTAL_ADENOMA_DN,SABATES_COLORECTAL_ADENOMA_DN,1/23,299/21728,0.273025975773477,0.3017436470057482,0.1953940712371161,SLC4A4,1
DURAND_STROMA_S_UP,DURAND_STROMA_S_UP,1/23,300/21728,0.27380624562074996,0.3021454004186358,0.19565422662317472,SLC4A4,1
WALLACE_PROSTATE_CANCER_RACE_UP,WALLACE_PROSTATE_CANCER_RACE_UP,1/23,303/21728,0.27614225171193674,0.30426007977379044,0.19702358704771045,XAF1,1
REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION,REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION,1/23,305/21728,0.27769559407271793,0.30550729241687485,0.19783121948156251,COG5,1
TARTE_PLASMA_CELL_VS_PLASMABLAST_DN,TARTE_PLASMA_CELL_VS_PLASMABLAST_DN,1/23,307/21728,0.2792457477125365,0.30658843552440673,0.19853131360273746,AFF1,1
REACTOME_LEISHMANIA_INFECTION,REACTOME_LEISHMANIA_INFECTION,1/23,308/21728,0.2800196307153192,0.30658843552440673,0.19853131360273746,VAV3,1
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4,1/23,309/21728,0.28079271888028423,0.30658843552440673,0.19853131360273746,AFF1,1
HORIUCHI_WTAP_TARGETS_UP,HORIUCHI_WTAP_TARGETS_UP,1/23,309/21728,0.28079271888028423,0.30658843552440673,0.19853131360273746,CROT,1
WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING_PATHWAY,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING_PATHWAY,1/23,309/21728,0.28079271888028423,0.30658843552440673,0.19853131360273746,IKBKB,1
LIU_SOX4_TARGETS_DN,LIU_SOX4_TARGETS_DN,1/23,310/21728,0.2815650129867203,0.30696937506071015,0.19877799096490273,ITSN2,1
DOUGLAS_BMI1_TARGETS_DN,DOUGLAS_BMI1_TARGETS_DN,1/23,314/21728,0.2846462643875032,0.3098626751966063,0.2006515472053524,COG5,1
LI_INDUCED_T_TO_NATURAL_KILLER_UP,LI_INDUCED_T_TO_NATURAL_KILLER_UP,1/23,315/21728,0.28541459986518547,0.31023326072302765,0.20089151982935805,OSBPL3,1
ZWANG_DOWN_BY_2ND_EGF_PULSE,ZWANG_DOWN_BY_2ND_EGF_PULSE,1/23,317/21728,0.28694890340059975,0.3114340643195132,0.20166910008929642,VAV3,1
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN,RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN,1/23,321/21728,0.290008062444176,0.31428377469660324,0.20351442978538672,SMAD3,1
GRESHOCK_CANCER_COPY_NUMBER_UP,GRESHOCK_CANCER_COPY_NUMBER_UP,1/23,323/21728,0.2915329302992343,0.3145258548615251,0.2036711887742145,AFF1,1
JAATINEN_HEMATOPOIETIC_STEM_CELL_UP,JAATINEN_HEMATOPOIETIC_STEM_CELL_UP,1/23,323/21728,0.2915329302992343,0.3145258548615251,0.2036711887742145,VAV3,1
LEI_MYB_TARGETS,LEI_MYB_TARGETS,1/23,323/21728,0.2915329302992343,0.3145258548615251,0.2036711887742145,SMAD3,1
LINDGREN_BLADDER_CANCER_CLUSTER_3_UP,LINDGREN_BLADDER_CANCER_CLUSTER_3_UP,1/23,327/21728,0.2945732734567045,0.3173337641249788,0.20548945016296274,SLC25A40,1
FARMER_BREAST_CANCER_APOCRINE_VS_BASAL,FARMER_BREAST_CANCER_APOCRINE_VS_BASAL,1/23,329/21728,0.29608876103695425,0.3184931034893054,0.20624018026312918,CROT,1
REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1/23,331/21728,0.2976011341176631,0.31964566257082333,0.2069865197917782,P2RY1,1
YANG_BCL3_TARGETS_UP,YANG_BCL3_TARGETS_UP,1/23,333/21728,0.2991103988091137,0.3207914780127329,0.20772849247721073,CROT,1
WONG_EMBRYONIC_STEM_CELL_CORE,WONG_EMBRYONIC_STEM_CELL_CORE,1/23,335/21728,0.3006165612101718,0.3217851968955401,0.20837197504959842,PIPOX,1
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN,KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN,1/23,336/21728,0.3013684809545817,0.3217851968955401,0.20837197504959842,AFF1,1
WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,1/23,336/21728,0.3013684809545817,0.3217851968955401,0.20837197504959842,IKBKB,1
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP,DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP,1/23,339/21728,0.3036196034796036,0.32371207723928325,0.20961972624133626,PIPOX,1
BLUM_RESPONSE_TO_SALIRASIB_DN,BLUM_RESPONSE_TO_SALIRASIB_DN,1/23,341/21728,0.30511649548880215,0.3248303366070214,0.21034385499343966,VAV3,1
JOHNSTONE_PARVB_TARGETS_2_DN,JOHNSTONE_PARVB_TARGETS_2_DN,1/23,342/21728,0.3058637868622416,0.3251484537758433,0.21054985173724305,SLC25A40,1
WP_PI3KAKT_SIGNALING_PATHWAY,WP_PI3KAKT_SIGNALING_PATHWAY,1/23,345/21728,0.3081010515231636,0.32704723624347526,0.2117794081518548,IKBKB,1
YOSHIMURA_MAPK8_TARGETS_DN,YOSHIMURA_MAPK8_TARGETS_DN,1/23,357/21728,0.31698132936282497,0.33598167220474867,0.21756490134783008,SLC4A4,1
COLINA_TARGETS_OF_4EBP1_AND_4EBP2,COLINA_TARGETS_OF_4EBP1_AND_4EBP2,1/23,359/21728,0.3184507358621371,0.33606518704519567,0.217618981375183,OSBPL3,1
GRUETZMANN_PANCREATIC_CANCER_UP,GRUETZMANN_PANCREATIC_CANCER_UP,1/23,359/21728,0.3184507358621371,0.33606518704519567,0.217618981375183,SMAD3,1
PEREZ_TP63_TARGETS,PEREZ_TP63_TARGETS,1/23,359/21728,0.3184507358621371,0.33606518704519567,0.217618981375183,ITSN2,1
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN,1/23,360/21728,0.3191843047270896,0.33634973971968013,0.21780324343372395,TTC12,1
GOLDRATH_ANTIGEN_RESPONSE,GOLDRATH_ANTIGEN_RESPONSE,1/23,366/21728,0.3235698832954643,0.34047629229203435,0.2204753921774916,MDFIC,1
DELACROIX_RARG_BOUND_MEF,DELACROIX_RARG_BOUND_MEF,1/23,367/21728,0.32429818086517714,0.3407480885902224,0.22065139384571936,OSBPL3,1
WANG_LMO4_TARGETS_UP,WANG_LMO4_TARGETS_UP,1/23,369/21728,0.3257525264897345,0.34178087077432345,0.22132017185531513,CROT,1
REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1/23,374/21728,0.32937530274673343,0.34508250649043604,0.22345814576367987,PIPOX,1
REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1/23,377/21728,0.33154002338699606,0.34634944806278406,0.22427855366388635,IKBKB,1
ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN,ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN,1/23,377/21728,0.33154002338699606,0.34634944806278406,0.22427855366388635,VAV3,1
LINDGREN_BLADDER_CANCER_CLUSTER_1_DN,LINDGREN_BLADDER_CANCER_CLUSTER_1_DN,1/23,378/21728,0.33226011047716053,0.3466022735193401,0.22444227076533682,ITSN2,1
BENPORATH_ES_1,BENPORATH_ES_1,1/23,379/21728,0.33297945555720865,0.34685359953875905,0.22460501690640514,PIPOX,1
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP,CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP,1/23,385/21728,0.3372799846505137,0.3508292523265745,0.22717945050838806,ZNF12,1
LINDGREN_BLADDER_CANCER_CLUSTER_2B,LINDGREN_BLADDER_CANCER_CLUSTER_2B,1/23,389/21728,0.3401322560369394,0.35328923442232246,0.22877241169126075,AFF1,1
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP,WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP,1/23,392/21728,0.3422637498411871,0.35499459032168906,0.22987671474914464,XAF1,1
JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP,JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP,1/23,395/21728,0.34438865695720144,0.3566882518485301,0.2309734451171607,SMAD3,1
OSMAN_BLADDER_CANCER_UP,OSMAN_BLADDER_CANCER_UP,1/23,401/21728,0.34861878879618324,0.36055438213585284,0.2334769574338881,SLC25A40,1
PEDRIOLI_MIR31_TARGETS_DN,PEDRIOLI_MIR31_TARGETS_DN,1/23,412/21728,0.35630631698282333,0.3674567280406073,0.23794657089816462,SAMD9,1
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,1/23,412/21728,0.35630631698282333,0.3674567280406073,0.23794657089816462,SMAD3,1
FOSTER_TOLERANT_MACROPHAGE_DN,FOSTER_TOLERANT_MACROPHAGE_DN,1/23,414/21728,0.357694693257798,0.36836456336918116,0.23853443958280196,AFF1,1
IBRAHIM_NRF1_UP,IBRAHIM_NRF1_UP,1/23,419/21728,0.36115311346660717,0.371398591862823,0.2404991244585395,ITSN2,1
MULLIGHAN_MLL_SIGNATURE_2_UP,MULLIGHAN_MLL_SIGNATURE_2_UP,1/23,423/21728,0.3639070178904106,0.37370054953335363,0.24198975693920255,IKBKB,1
MOOTHA_HUMAN_MITODB_6_2002,MOOTHA_HUMAN_MITODB_6_2002,1/23,431/21728,0.36938079938942114,0.37878511960018435,0.24528226982458404,SLC25A40,1
REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,1/23,432/21728,0.3700618456219439,0.3789475114066516,0.24538742662412577,SMAD3,1
ODONNELL_TFRC_TARGETS_UP,ODONNELL_TFRC_TARGETS_UP,1/23,434/21728,0.3714218281003312,0.3798037029234698,0.24594185336314714,IKBKB,1
GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN,GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN,1/23,438/21728,0.3741333725144581,0.382037598694341,0.24738841236686188,PIPOX,1
GARY_CD5_TARGETS_DN,GARY_CD5_TARGETS_DN,1/23,440/21728,0.3754849455147743,0.382878460616331,0.24793291242814325,SAMD9,1
MITSIADES_RESPONSE_TO_APLIDIN_UP,MITSIADES_RESPONSE_TO_APLIDIN_UP,1/23,445/21728,0.37885167456746083,0.3857689101986083,0.24980462279285565,SMAD3,1
SENESE_HDAC1_TARGETS_UP,SENESE_HDAC1_TARGETS_UP,1/23,451/21728,0.3828688354093358,0.3893126306756921,0.2520993586662196,COBLL1,1
MIKKELSEN_NPC_ICP_WITH_H3K4ME3,MIKKELSEN_NPC_ICP_WITH_H3K4ME3,1/23,452/21728,0.3835359415232422,0.38944475854951066,0.2521849180589209,TTC23,1
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP,CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP,1/23,454/21728,0.38486808501083636,0.3902508554305683,0.2527069060211013,VAV3,1
MARTENS_BOUND_BY_PML_RARA_FUSION,MARTENS_BOUND_BY_PML_RARA_FUSION,1/23,456/21728,0.3861974747142096,0.39105191224553343,0.2532256302889408,SMAD3,1
MEBARKI_HCC_PROGENITOR_FZD8CRD_DN,MEBARKI_HCC_PROGENITOR_FZD8CRD_DN,1/23,459/21728,0.3881864078086663,0.39197095496000434,0.25382075631529866,XAF1,1
SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6,SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6,1/23,459/21728,0.3881864078086663,0.39197095496000434,0.25382075631529866,ARFGEF2,1
REACTOME_GPCR_LIGAND_BINDING,REACTOME_GPCR_LIGAND_BINDING,1/23,463/21728,0.39082873099134086,0.39409016685496817,0.25519305178557655,P2RY1,1
GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN,GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN,1/23,467/21728,0.3934601365236985,0.39619249858289085,0.25655441650521865,SMAD3,1
ONDER_CDH1_TARGETS_2_DN,ONDER_CDH1_TARGETS_2_DN,1/23,473/21728,0.3973868683939912,0.3995915112144849,0.25875544682636703,COBLL1,1
GARY_CD5_TARGETS_UP,GARY_CD5_TARGETS_UP,1/23,474/21728,0.3980389550572204,0.39969285653252745,0.258821072977869,SUCLG2,1
BROWNE_HCMV_INFECTION_48HR_DN,BROWNE_HCMV_INFECTION_48HR_DN,1/23,485/21728,0.4051675064566149,0.4057271300843175,0.2627285662687559,MDFIC,1
MATSUDA_NATURAL_KILLER_DIFFERENTIATION,MATSUDA_NATURAL_KILLER_DIFFERENTIATION,1/23,485/21728,0.4051675064566149,0.4057271300843175,0.2627285662687559,MDFIC,1
LIU_PROSTATE_CANCER_DN,LIU_PROSTATE_CANCER_DN,1/23,491/21728,0.4090216995506718,0.4090216995506718,0.2648619644277309,VAV3,1
